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Streptococcus sanguinis is an important component of the dental plaque biofilm 
and is believed to play a beneficial role in the oral cavity. S. sanguinis is also a leading 
cause of infective endocarditis (IE), a potentially lethal infection of the cardiac valves. S. 
sanguinis possesses genetic competence, the ability to acquire exogenous DNA into its 
genome. In the well characterized system of S. pneumoniae, genetic competence requires a 
quorum sensing system encoded by the early comCDE genes, as well as late genes 
   
 xvii
controlled by the alternate sigma factor, ComX. Previous studies in other streptococcal 
species have suggested functions for the com regulon apart from DNA uptake. Here we 
characterized functions of the S. sanguinis com regulon genes in genetic competence, IE 
virulence, and biofilm formation. Our findings indicated that the early regulatory genes and 
those under the control of ComX in S. sanguinis play similar roles in genetic competence 
as their orthologs in other competent streptococci; however the sequence and mechanism 
of processing of the quorum sensing signal, competence-stimulating peptide, CSP, were 
determined to be unique.  Using a rabbit endocarditis model, we determined that the 
comCDE and comX genes were not required for virulence, bacteremia, or pathology under 
a variety of infection conditions. In contrast, examination of biofilms by microscopy and 
crystal violet staining indicated that S. sanguinis CSP enhanced biofilm formation in a 
comDE-dependent manner. Deletion of the early com gene SSA_0195 eliminated this 
effect, while expression of the gene from an inducible promoter increased biofilm 
formation in the absence of CSP. Deletion of the comX gene resulted in biofilms with 
increased staining, cell death, and profoundly altered structure. Treatment with DNase I 
reduced biofilm formation in a com-independent manner. Taken together, these results 
suggest that expression of SSA_0195 is both necessary and sufficient for CSP-dependent 
biofilm enhancement, and that the late gene activator, ComX, is required to maintain 
normal biofilm architecture. Our findings suggest the com regulon of S. sanguinis may be 
an important determinant of competitiveness in the mouth, where native CSP production 
may occur at levels sufficient to influence biofilm formation.  
  1 
 
 
CHAPTER 1: INTRODUCTION 
 
Streptococci  
The streptococci consist of Gram positive, catalase-negative, non-motile, 
microaerobic and non-spore forming bacteria. They divide in a single plane resulting in 
characteristic chains or diplococci.   The earliest known attempts for classification of the 
streptococci were performed in 1903 by Shotmuller et al, and were based upon hemolysis 
patterns on blood agar plates (41). The three main types of hemolysis patterns observed 
within Streptococcus are alpha-hemolysis in which strains partially lyse red blood cells 
(RBC) and colonies have a green halo on the plate, beta-hemolysis where strains 
completely lyse RBC, resulting in a clearing around colonies, and gamma-hemolysis, 
which is the name given to an absence of hemolysis.  Later classifications described by 
Lancefield (85) involved classification of the beta-hemolytic species into immunological 
groups based on the presence of specific cell wall antigens. 
The classification of the streptococci has long remained a problematic area of 
taxonomy (14).  Within the past 30 years, the classification of the streptococci has 
undergone many changes due to the recent increase in 16S rRNA sequencing, 16S – 23S 
intergenic spacer sequencing, cluster analysis, multilocus sequence analysis (MLSA) and 
DNA-DNA hybridization (3, 14, 41, 155).  The genus Streptococcus now includes over 
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fifty species, most of which have been placed into six major phylogenetic groups based 
upon 16S rRNA sequencing– the Pyogenic streptococci, Mitis, Anginosus, Salivarius, 
Mutans, and Bovis groups (14). The viridans streptococci include Mitis, Anginosus, and 
Salivarius groups. 
 
Viridans Streptococci  
 The term “viridans streptococci” refers to the alpha hemolysis pattern observed on 
blood plates which is characterized by a green pigmentation, due to oxidation of 
hemoglobin in RBC (7). In the past, the terms “oral streptococci” and “viridans 
streptococci” have been used interchangeably.  However care should be used when 
employing these terms. Several of the recognized viridans species include beta- and 
gamma- hemolytic species, or may occupy niches outside the mouth (164). These may 
include the genital tract (134) or intestines (160).  The majority of oral and viridans 
streptococci, however, can be located in the hard and soft tissue of the oral cavity and 
within the nasopharynx, and most studies have focused on their role within this niche.  
 
Biofilms and oral streptococci 
Biofilms are organized communities of surface adherent microorganisms embedded 
in an exopolysaccharide matrix (EPS). The components of the EPS can contain a wide 
variety of polysaccharides, proteins, glycoproteins, and extracellular DNA (eDNA). DNA 
was first identified as a component of the extracellular matrix in Pseudomonas aeruginosa 
biofilms(165). Biofilms may consist of dense clusters of bacterial cells which aggregate 
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together.  Biofilm formation occurs in a series of distinct steps including initial adherence, 
irreversible attachment, maturation, and dispersion(117).  Unlike planktonic cells, bacterial 
cells living within a biofilm may exhibit increased resistance to antimicrobial agents and 
the immune response of the host (15).   
Biofilms may consist of one species of bacteria or several species, as in the case of 
dental plaque (146). The oral plaque biofilm comprises more than 700 species, of which 
approximately 20% are streptococci (1).  Predominant species occurring in dental plaque 
can be divided into early colonizers, bridge species, and late colonizers.   Streptococci are 
among the earliest colonizers on a freshly cleaned tooth surface (79, 91, 149). Adherence 
occurs through specific receptor-ligand interactions on the bacterial cell surface and the 
acquired pellicle consisting of salivary glycoproteins (113) including salivary agglutinin 
and sialylated mucins (79). Important streptococcal early colonizers are members of the 
mitis group and include the species S. oralis, S. sanguinis, S. gordonii and S. mitis. 
However cariogenic species from the Mutans group (43) are also found on the tooth 
surface. Other early colonizers that bind to the streptococcal species include Haemophilus 
parainfluenzae, Capnocytophaga ochracea and Prevotella denticola.  Fusobacterium 
nucleatum is considered the bridge species between the early colonizers and the late 
colonizers, which can include species implicated in periodontitis, including 
Porphyromonas gingivalis, Prevotella intermedia, and Treponema denticola (79). 
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Streptococcus sanguinis  
 
Streptococcus sanguinis (formerly known as S. sanguis (154)) can be classified 
among the mitis group of viridans streptococci (72, 164).  S. sanguinis exists among 
normal oral flora as a pioneer colonizer of the tooth surface, serving as a tether for 
numerous bacteria within dental plaque (1, 78).  There is evidence that S. sanguinis is 
correlated with a “healthy plaque” as S. sanguinis is often associated with tooth surfaces 
free of caries (10). S. sanguinis may interfere with colonization of the tooth by S. mutans 
(19) and other oral pathogens (142). However, because of its presence on the teeth, S. 
sanguinis may easily be seeded into the bloodstream through oral surgery or everyday 
activities including chewing or brushing (138, 166). In persons with certain preexisting 
conditions that cause cardiac damage, blood-borne oral streptococci, including S. sanguinis 
(27, 37, 83), may adhere to the damaged tissue, resulting in infective endocarditis (166). 
 
Infective Endocarditis 
Infective endocarditis (IE) is a rare, yet highly lethal condition if left untreated. IE 
is an infection of the cardiac valves or endocardium most often caused by bacteria; 
however cases caused by fungi have been reported (13).    Each year in the U.S. there are 
approximately 15,000 new cases (123) with incidence higher in males than females by 
approximately two to three-fold (140).  Susceptibility to IE infection appears to increase 
with age as greater than half of all cases of IE are in those older than 60 years (123); 
however, incidence is increasing among younger individuals with a history of intravenous 
(IV) drug use (104). Depending on the severity of clinical presentation, classification, and 
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level of progression, IE can be characterized as “acute” or “subacute- chronic” (114).  IE 
can be classified into four main categories including native valve endocarditis (NVE), 
prosthetic-valve endocarditis (PVE), infective endocarditis in IV drug users, and 
nosocomial IE (108).   
Risk factors for NVE include rheumatic heart disease, congenital heart disease 
(108), and mitral valve prolapses (MVP) (114).  Most cases of NVE manifest as “left 
sided,” that is most commonly occurring in the mitral or aortic valves.  Among cases of 
NVE, approximately 44% are caused by the staphylococci and 31% by streptococci (108).  
Among the streptococci, oral streptococci are the most common cause of IE, with 
Streptococcus sanguinis frequently reported as the most commonly isolated oral species 
(27). 
Approximately 1-5% of IE cases result from the introduction of a prosthetic valve.  
PVE can be classified as early or late, depending on whether infection occurred within the 
first 2 months of surgery or later.  Early cases of PVE are most often due to S. epidermidus 
or S. aureus, while later cases involved streptococci and the Gram negative HACEK group 
(Haemophilus spp., Actinobacillus actinomycetemcomitans, Cardiobacterium hominus, 
Eikenella corrodens, and Kingella kingae) (108, 114).  With regard to nosocomial IE, most 
cases are caused by the enterococci and staphylococci with many patients lacking cardiac 
predisposing factors and introduction of bacteria occurring through catheters (108).  IV 
drug users more often present with the right side (tricuspid valve) IE, with organisms often 
entering from the skin, with S. aureus as the most common and Pseudomonas also 
prevalent (108).    
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IE Clinical Manifestations, Diagnosis, Treatment 
 Many cases of IE are left undiagnosed due to nonspecific symptoms, mimicking the 
flu. These include fever, weight loss, general malaise, loss of appetite and night sweats. 
The presence of a heart murmur can also be indicative of IE, although in many patients this 
is a preexisting condition due to valve dysfunction.  Peripheral manifestations include 
petechiae on the skin, conjunctiva and oral mucosa, splinter hemorrhages under the nails, 
Osler’s nodes (tender, subcutaneous nodules on the digits), and Janeway’s lesions 
(hemorrhagic lesions on the soles of the feet) (114, 115).  
 Definitive diagnosis of IE requires incorporating clinical symptoms, 
microbiological isolation and identification, and transesophageal echocardiogram (TEE) 
examination.   These parameters collectively known as the “Duke’s criteria” were 
established in 1994, by David Durack at Duke University (35) and modified in 2000 to 
incorporate S. aureus, Coxiella burnetti, and negative blood cultures (92).  Duke’s criteria 
can be divided into major criteria and minor criteria.  Major criteria involve a positive 
blood culture of typical IE organisms (including viridans streptococci, S. aureus, 
enterococci, and the HACEK group.)  These blood identifications must involve either two 
positive draws twelve hours apart, or three to four positive draws spread out over an hour. 
Another major criterion for IE is a positive echocardiogram, which may allow visualization 
of an oscillating mass on a valve, abscess, or partial dehiscence of a prosthetic valve.  
Minor criteria involve history of IV drug use, and presence of symptoms described above. 
Diagnosis may be definite, possible or rejected depending on the number and combination 
of both major and minor criteria seen (108).    
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Currently there is no vaccine for IE. Prevention of IE has traditionally relied on 
prophylactic treatment with antibiotics before dental or other surgeries that induce 
bacteremia.  However the efficacy of this prophylaxis has been called into question, as the 
number or cases of IE has remained steady throughout the years and there is little evidence 
of protection from such measures.  Further, increasing evidence exists that oral bacteria 
may enter the blood through everyday activities including tooth brushing or chewing (45, 
51, 135).  Also due to the steady increase in antibiotic resistance, risk of anaphylaxis, and 
seemingly rare incidence in IE within the population, recent revisions in prevention 
strategies have focused on maintenance of good oral hygiene, rather than administering 
antibiotics.  In 2007, the American Heart Association made modifications to its guidelines 
in the prevention of IE, greatly limiting those who are recommended to receive such 
prophylaxis.  However for at-risk individuals undergoing procedures in which significant 
bleeding of the gingival tissue or periapical region is expected, a single oral dose of 2g 
amoxillicin  may be administered thirty to sixty minutes prior to procedure (166). 
 
IE Pathogenesis of Oral Streptococci 
NVE pathogenesis is thought to occur in a series of distinct steps.  Most cases of 
NVE occur in patients with pre-existing damage to the cardiac valve endothelium, in which 
the deposition of extracellular matrix proteins, fibrin, and platelets form a “vegetation”. 
Oral streptococci may be introduced into the bloodstream through a bacteremic event such 
as brushing, chewing and/ or oral dental procedures.  In the first step, which occurs within 
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minutes of a bacteremic event, bacteria adhere to the vegetation tissue. This adherence may 
involve a family of sialic acid-binding adhesins (73, 147). 
The second step involves establishment and persistence of the bacteria within the 
site of attachment.  In the third step, microbial growth continues and may be coupled with 
tissue damage resulting from the persistence of monocytes producing tissue factor activity 
(TFA) and cytokines.  In the last step, dissemination to distant tissue including the kidneys 
and brain may occur (108, 109) resulting in such conditions as stroke, brain abscesses, 
glomerulonephritis, and ultimately death if left untreated (123). 
 
Genetic competence 
Genetic competence refers to the ability of certain bacteria to take up and 
incorporate free exogenous DNA (146).  Genetic competence is believed to be 
instrumental for bacteria to adapt to their environment and often contributes to an increase 
in clinical severity, as in the case of uptake of antibiotic resistance genes. In bacteria, the 
incorporation of naked DNA into the genome is known as transformation. Transformation 
was first observed in S. pneumoniae by Griffith in 1928 (48) when he noted a heat killed 
virulent strain mixed with a live avirulent strain could be lethal. It was later determined 
that DNA was the transforming factor (6). DNA uptake has been well studied in both the 
gram positive and gram negative bacteria. Within the gram positive bacteria, studies in 
Bacillus subtilis and S. pneumoniae have demonstrated three main steps are involved. In 
the first of these steps, dsDNA binds to the cell surface, next the bound DNA undergoes 
fragmentation, and lastly ssDNA is transported into the cell while the untransported strand 
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is degraded (32). Further, it has been observed that binding of dsDNA does not require 
sequence specificity in either S. pneumoniae or B. subtilis (46). 
 
Genetic competence in the streptococci 
The process of transformation is best understood in the mitis group species, S. 
pneumoniae, where it was initially discovered. Within this species, it was first observed 
that a culture’s ability to be transformed is dependant upon cell density and would 
diminish rapidly over time (152). Such observations suggested a model of quorum sensing 
(QS), in which bacteria can communicate with each other in response to environmental 
conditions (106).  Additional studies by Tomasz et al indicated the presence of a secreted 
competence factor (151) which could be isolated from supernatant of competent strains 
(150).  Later studies by Havarstein et al identified this secreted factor, competence-
stimulating peptide (CSP) encoded by comC (56). S. pneumoniae ComC is produced as a 
41 amino acid precursor peptide which is then processed and secreted to its active form, 
CSP, a 17 amino acid peptide. 
Studies were performed to identify and map additional com genes using insertion-
duplication mutagenesis (20) and revealed the presence of two neighboring genes, comA 
and comB encoding proteins of 77kDa and 49 kDa respectively (21).  When either of these 
genes was deleted, competence was lost but restored in the presence of added secreted 
competence factor (20). Sequence analysis of ComA indicated it was a member of the 
ATP-binding cassette transporter family, suggesting it was responsible for secretion of 
CSP (66).  ComA and ComB demonstrated strong sequence similarities to proteins 
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involved in the transport of Gly-Gly bacteriocins (67).  Proteins of this family are known 
to recognize this double glycine motif and cleave the prepeptide to its active form 
concomitant with export (21, 30, 69).The sequence of ComC within S. pneumoniae and 
most other competent streptococci possess this GG motif . Later studies in S. pneumoniae 
ATCC 49619 revealed residues Cys17 and His96 of ComA are essential for proteolytic 
activity (69). 
Additional sequencing downstream of comC revealed the presence of comD and 
comE (128), which demonstrated homology to two component regulatory systems (143).  
ComD and ComE exhibit a high level of homology to the transmembrane histidine kinase 
proteins (HK) and response regulator (RR) families, respectively (128).   In a typical 
cascade, a stimulus activates the HK and adenosine triphosphate (ATP) phosphorylates 
histidine residues, which next transfers a phosphoryl group to their cognate RR on a 
conserved aspartic acid residue (143). It was therefore proposed that CSP was the stimulus 
activating this TCS, with RR ComE upregulating comAB and comCDE (128).  It was 
demonstrated by Havarstein et al that ComD served as the receptor of CSP (58), and Ween 
et al elucidated the DNA binding activity of ComE (162). Ween’s study demonstrated that 
ComE functions autocatalytically by binding to its own promoter and upstream of comAB. 
The binding site of ComE was shown to be a ≈ 9- bp direct repeat of aCAtTTcaG (162) 
separated by 12 or 13 nucleotides (28). 
Using a variety approaches including genome sequencing, bioinformatics and 
genomic libraries, additional competence genes involved in DNA uptake were identified.  
These included competence induced loci (cil) genes (18) which exhibited high levels of 
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homology to competence genes previously seen in B. subtilis, Haemophilus influenzae, and 
Neisseria gonorrhoeae. Among these genes, which were required for competence,  were 
homologues to cilA, a ssDNA binding protein, cilB, involved in DNA processing,  cilC, a 
prepilin peptidase, cilD involved in DNA binding and pilin production and cilE (comEA), 
involved in DNA binding and uptake (18). Genes within this locus all possessed a 
conserved upstream (-10) region of 8 nucleotides, TACGAATA, known as the com-box 
which was required for induction of these genes (18). This com-box was not observed 
upstream of comAB or comCDE, therefore suggesting induction of the cil locus by other 
means (88).  A search for this regulator used purified S. pneumoniae RNA polymerase 
holoenzyme, and revealed an interaction of a protein associated with cilA transcription, 
sigma factor ComX.  comX was present in two identical copies with the presence of either 
sufficient for competence. Activity of ComX was observed to be dependent upon ComE 
(88).  A later study on ComX revealed another protein, ComW, serves to stabilize and 
activate ComX by an unknown mechanism (145).   
Competence (com) genes have been separated into two groups based on temporal 
expression and whether there are controlled by ComE or ComX. Collectively, the ComE-
dependent genes,  are referred to as “early” because their expression is upregulated 
immediately following CSP addition, and reaches maximum levels between 7.5 and 10 
minutes post-induction (130).  The ComX-dependent genes are referred to as “late” 
because they experience a lag in induction after CSP addition and reach maximum levels at 
approximately 12.5 minutes post-induction (130).  Microarray analysis indicates that CSP 
upregulates approximately 124 genes in S. pneumoniae; however, only 23 of these have 
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been shown to be required for DNA uptake (131). Based on the identification of the 
aforementioned genes, a summary model of the S. pneumoniae com regulatory genes has 
been put forth and is illustrated in Fig.1. 
It has been observed that loss of ComA, ComB, or ComC results in diminishment 
of competence. Since these three proteins function to produce and export mature CSP, their 
loss can be overcome by the addition of synthetic CSP to the culture medium. Mutation of 
the genes encoding ComD, ComE, or ComX results in loss of competence, even in the 
presence of added CSP (131).  
Much of our understanding of S. pneumoniae com genes is based on the study of 
another competent Gram positive species, B. subtilis, as many genes were identified 
through homology searches (18, 87). Further, the mechanisms regulating genetic 
competence within B. subtilis are very similar to that of S. pneumoniae. In B. subtilis 
genetic competence occurs approximately two hours following the onset of stationary 
phase.  In B. subtilis competence is similarly regulated via a two component system (TCS) 
as follows.  First, extracellular, post- translationally modified, competence pheromone, 
ComX is sensed by HK, ComP which becomes phosphorylated.  ComP then transfers its 
phosphoryl group to response regulator ComA.  This interaction of ComA and ComP 
activates the transcription of comS. ComS in turn allows for accumulation of ComK 
through preventing its proteolysis. ComK is a transcriptional activator which drives 
expression of the com genes and serves in a positive feedback loop, further driving its own 
expression (153). 
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Figure 1. S. pneumoniae com regulon model   
 
1. comC gene encodes precursor peptide, ComC  
2. Com C is cleaved and exported by the products of the comAB operon, ABC 
transporter with peptidase activity, ComA, and integral membrane protein 
ComB. 
3. The mature ComC peptide, termed “competence stimulating peptide” (CSP) 
accumulates in the extracellular matrix and is sensed by the transmembrane 
(HK), ComD. ComD responds by activation through autophosphorylation of 
histidine residues. 
4. ComD then transfers phosphoryl groups to conserved aspartic acid residue on 
the ComE (RR). Phosphorylated ComE activates expression of the comAB and 
comCDE operons through binding the comE box. ComE also activates comX 
which is present in two identical copies.  
5. ComX serves as an alternative sigma factor, directing the expression of “late”  
genes required for uptake and incorporation of DNA. 
6.  Among the late genes are the comY operon, which encodes a pseudopilus,                              
involved in the binding of DNA with DNA receptors on the cell surface. 
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Figure 1. 
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The DNA uptake machinery is also similar within the two species. B. subtilis 
possesses a competence pseudopilus encoded by the seven gene operon, comG (16, 24) 
that allows exogenous DNA access to ComEA. ComEA is an integral membrane protein 
that binds DNA at the C-terminal domain, external to the cell (33).    ComEA orthologs 
have been shown to be essential for DNA transport in S. pneumoniae (32). Homologues to 
the comG operon within the streptococci occur in a four gene operon, known as cglA-D in 
S. pneumoniae (131) or comY-D in S. gordonii (99). 
In B. subtilis, cleavage of bound dsDNA occurs immediately through activity of 
endonuclease NucA (133).  Although mechanisms for the cleavage of dsDNA prior to cell 
entry in the streptococci are not fully understood, it has been demonstrated that single 
stranded nicks (84) in DNA occur followed by double stranded breaks (110). One strand is 
degraded by nuclease EndA (32).  Once DNA is has been linearized, it is transported into 
the cell by ComEC.  ComEC is a polytopic membrane protein with at least six membrane-
spanning segments. ComEC is believed to form an aqueous channel for DNA (32).  Once 
DNA enters the cell it is believed to recombine with the chromosome in a RecA- 
dependent process depending on a high level of homology between foreign and host DNA 
(11).  
Streptococcal species known to be naturally competent include S. pneumoniae, S. 
gordonii, S. sanguinis and S. mutans. The increase in whole genome sequencing and 
transcriptome analysis within the streptococci has increased our understanding of 
similarities and differences in mechanisms of competence existing within the genus. We 
now know that in S. gordonii (98), S. sanguinis (136) and S. pneumoniae (59), the onset of 
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competence occurs at early exponential phase.  Within S. pneumoniae many pherotypes of 
CSP exist, with two predominating (132, 163).  Additionally the comCDE operon is 
present within the anginosus groups (59), suggesting the regulatory mechanisms of 
competence may be similar within these groups.   
Within S. mutans several key differences from S. pneumoniae in the competence 
system have been identified.  In S. pneumoniae, competence induction occurs within five 
minutes of CSP exposure (131), while there is an approximate delay of two hours (2) in S. 
mutans. There has only been one pherotype of S. mutans identified, although minor 
variations may exist among strains (4).  Additionally, no binding motif for ComE is 
present in the promoter region of ComX in S. mutans, (90)and transformation frequency is 
much lower (112) than observed S. pneumoniae, being only ≈ 1% of the population.  
Further, microarray studies revealed a high proportion of CSP-upregulated genes related to 
bacteriocin production (127), suggesting the main function of this system is for production 
of bacteriocins rather than DNA uptake (159). 
 
com genes in S. sanguinis 
The genome of S. sanguinis SK36 has recently been sequenced and was shown to 
contain a single circular DNA molecule containing approximately 2.4 Mb. S. sanguinis is 
naturally competent, and it is estimated that at least 270 of its 2274 genes were acquired 
through horizontal gene transfer.  No evidence of conjugative plasmids or phage genes 
exists, suggesting natural transformation as the most frequent method of gene acquisition 
(168). We have recently noted several key similarities and differences in genetic 
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competence in S. sanguinis compared to S. pneumoniae.  Competence was found to 
develop in S. sanguinis during the early exponential growth phase (OD660 ≈ 0.070) (136), 
as in S. pneumoniae (56, 152).  Microarray and RT-PCR studies performed with a comC 
mutant suggested upregulation of 124 genes in S. sanguinis in response to CSP (136).  
Further, the sequencing of S. sanguinis revealed four putative orthologs of the early 
regulatory genes of genetic competence, the comCDE operon and comX. However the 
sequencing of S. sanguinis failed to identify comAB or comW orthologs (168).   
ComC maturation and secretion in the streptococci 
 
From what is known of competence induction in S. pneumoniae, it is clear that a 
key step in the initiation of competence is the cleavage and export of ComC to produce 
extracellular CSP. The S. pneumoniae ComC cleavage site was identified by isolation and 
sequencing of the mature CSP molecule (56). Alignment of the ComC sequence of S. 
pneumoniae with that of several other streptococci demonstrates a conserved glycine-
glycine (GG) motif just upstream from the cleavage site (Fig. 2). This places S. 
pneumoniae ComC within a large family of peptides that undergo cleavage at a GG motif 
concomitant with export t(30). Likewise, the ComA ABC transporter that was shown to be 
responsible for cleavage of ComC in S. pneumoniae (66) contains a motif that exhibits 
strong homology to the Peptidase C39 family (67). Proteins in this family are known to 
recognize the GG motif and cleave the prepeptide to its active form concomitant with 
export (21, 30, 69). Other peptides that contain the GG motif, including bacteriocins, have 
also been shown to be processed by peptidases belonging to this family (29, 30, 70). In 
gram positive bacteria, bacteriocins are small heat stable peptides that are used to enhance 
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colonization by eliminating competing strains or species.  ComB is required for CSP 
transport in S. pneumoniae and has homology to bacteriocin transport proteins, but its 
exact function is not known (67).   Figure 2 indicates that S. sanguinis ComC lacks a 
characteristic GG cleavage signal; however, Havarstein et al reasoned that cleavage likely 
occurred after the FW due to the conserved Arg residue in the +3 position. Further, this 
group demonstrated that a synthetic peptide with sequence DLRGVPNPWGWIFGR 
stimulated competence in S. sanguinis (59).   
This suggests that S. sanguinis ComC is also cleaved, although probably not by a 
Peptidase C39 family member. This likely explains why ComA orthologs have been 
readily identified in every species listed in Fig. 2 except S. sanguinis, despite the 
availability of the S. sanguinis genome sequence (168). As seen in Fig. 2, the sequence of 
ComC in S. sanguinis appears to be unique, and a BlastP (5) search for S. sanguinis ComC 
homologs does not produce any significant matches. Further, a Blocks database analysis 
(62) showed that S. sanguinis ComC did not appear to have homology to motifs in any 
known family of peptides, and the exact sequence of secreted CSP remains unknown. 
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Figure 2. ComC sequences of S. sanguinis and other naturally competent 
streptococci.  
 
Underlined sequences indicate demonstrated or proposed cleavage recognition sequences. 
Sequences occurring after the dash indicate demonstrated or proposed sequences of the 
mature, cleaved CSP from each species. 
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Figure 2. 
S. pneumoniae                MKNTVKLEQFVALKEKDLQKIKGG-EMRLSKFFRDFILQRKK                           
S. oralis                    MKNTVKLEQFVALKEKDLQEIKGG-EMRLPKILRDFIFPRKK           
S. mitis                     MKNTVKLEQFKEVTEAELQEIRGG-DWRISETIRNLIFPRRK            
S. infantis                  MEKTVKLEQFKKLTEKELQEIQGG-DWRFLNSIRDLIFPKRK           
S. cristatus             MKNTQKNFKTIAQFPVLNEKELKEVLGG-DLRNIFLKIKFKKK              
S. oligofermentans       MKNTQKNFKTIAYFPVLNEKELKEVFGG-DSRNILKIKFKKK                               
S. constellatus      MKKIFSKKEITKVEVESFKELTDEQLNKIVGG-DSRIRMGFDFSKLFGK            
S. anginosus         MKKLFAKKEVVKKEVVEFKELNDEQLDKIIGG-DSRIRMGFDFSKLFGK            
S. milleri           MKKIFSKKEITKVEVESFKELTDEQLNKIVGG-DRRDPRGIIGIGKKLFG 
S. gordonii           MKKKNKQNLLPKELQQFEILTERKLEQVTGG-DVRSNKIRLWWENIFFNKK       
S. mutans                   MKKTLSLKNDFKEIKTDELEIIIGG-SGSLSTFFRLFNRSFTQALGK       
S. sanguinis SK36                MKIYSFQIALNSNSLVQTFW-DLRGVPNPWGWIFGR            
S. sanguinis NCTC 7863           MKIYSFQIAANSNSLVQTFW-DLRGVPNPWGWIFGR 
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Research Objectives 
S. sanguinis plays a benign or beneficial role within the mouth; however, it is a 
leading cause of infective endocarditis, a potentially fatal infection of the cardiac valves.  
Within other streptococcal species, genetic competence genes have been seen to contribute 
to both virulence and persistence in the oral biofilm, dental plaque.  Recent sequencing of 
S. sanguinis has revealed this regulon has helped to shape its genome; however orthologs 
of important streptococcal regulatory competence (com) genes were not identified. This 
includes the gene(s) necessary for processing and secretion of the competence quorum 
sensing signal, CSP, or competence stimulating peptide. The goal of the project described 
here is to further characterize the mechanism of genetic competence within Streptococcus 
sanguinis, and in doing this, determine the role of this system in endocarditis virulence and 
biofilm formation.  This was addressed through three key aims. In the first aim, mutants of 
com ortholog genes were constructed and analyzed for competence, the mature CSP was 
isolated and identified, and candidates for its processing and transport were tested.    In the 
second aim, endocarditis virulence was assessed in mutants of the com regulatory genes 
relative to a virulent wild type strain using a well characterized rabbit model. In the third 
aim, roles of the com regulon in biofilm formation were evaluated using staining and 
microscopy.  We uncovered novel regulatory mechanisms existing with the com regulon of 
S. sanguinis. Additionally, we sought to determine mechanisms to inhibit endocarditis 
virulence without eliminating the benefits of S. sanguinis persistence within the mouth.  
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CHAPTER 2: MATERIALS AND METHODS 
 
Bacterial strains and growth conditions 
S. sanguinis SK36, isolated from human dental plaque (74, 168), was used in these 
studies. Strains derived from SK36 and plasmids used in this study are listed in Table 1. 
SK36 and derivates were grown at 37° C in Anoxomat jars (Spiral Biotech) under 
microaerobic conditions (7.2% H2, 7.2 % CO2, 79.6% N2, and 6% O2) or anaerobic 
conditions on Brain Heart Infusion (BHI; Bacto, Sparks, MD) plates with 1.5% agar or in 
BHI broth, except as noted below. For transformations, S. sanguinis strains were grown in 
Todd Hewitt broth (Bacto, Sparks, MD) adjusted to pH 7.6 containing 2.5% horse serum 
(Invitrogen) (THHS) (122, 156)and incubated with transforming DNA. For streptococcal 
selection, chloramphenicol (Cm), erythromycin (Em), spectinomycin (Sc) and kanamycin 
(Kn) were employed at 5 μg/ml, 10 μg/ml, 200 μg/ml, and 500 μg/ml, respectively. Strains 
were cryopreserved in media with respective antibiotic plus 30% glycerol at -80 °C.   
Electromax DH10B (Invitrogen) was used as the host strain for plasmid construction in 
Escherichia coli. Em and Sc were added to Luria-Bertani medium or terrific broth (TB) 
(148)at concentrations of 300 μg/ml and 50 μg/ml, respectively for selection. 
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Table 1. Strains and plasmids used in this study 
 
Strain or plasmid  Description Reference 
S. sanguinis 
Strains   
 
SK36 
 
Human plaque isolate 
 (74, 168)      
JFP41 ΔcomC; derived from SK36 (136)    
JFP36 Emr; SSA_0169::pSerm; derived from SK36 (156)      
JFP45 Knr; ΔcomX::aphA-3; derived from SK36 This study 
JFP49  Scr; ΔcomCDE::aad9; derived from SK36 This study 
JFP60 ΔcomC, ΔcomX::aphA-3; derived from JFP41 This study 
JFP61  
               
Scr; ΔSSA_1889::aad9; Knr ΔSSA_0195::aphA-3, 
derived from SK36 
This study 
 
JFP65      Scr; ΔSSA_1889::aad9; derived from SK36 This study 
Ssx_0195 Knr; ΔSSA_0195::aphA-3, derived from SK36 (23)      
JFP95             Knr; ΔSSA_0195::aphA-3(pJFP94) This study 
JFP96 ΔcomC (pJFP94) This study 
JFP97 ΔcomC (pVA838) This study 
JFP98             Knr; ΔSSA_0195::aphA-3(pVA838) This study 
JFP113 ΔcomC, ΔcomX::aphA-3 (pJFP94)  This study 
JFP114 ΔcomC, ΔcomX::aphA-3 (pVA838)  This study 
Plasmids   
pJFP16 
 
Knr Cmr; pVA2606 containing 3.3 kb  
nrdD1::magellan2 
(156)      
 
pVA838 Emr; E. coli-Streptococcus shuttle vector (100)      
pDR110 Scr; bla amyE::Pspank D. Rudner 
pJFP93 Scr; pDR110 containing SSA_0195 fused to Pspank This study 
pJFP94 
 
 
Emr; pVA838 containing 2.5-kb EcoRI/BamHI 
fragment from pJFP93 comprised of SSA_0195 fused 
to Pspank  
This study 
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DNA Manipulations  
 
 Chromosomal S. sanguinis, SK36 DNA was isolated as described previously (75).  
DNA amplification by PCR was routinely performed in an MJ Research PCT-200 thermal 
cycler (Bio-Rad). PCR amplification was performed using Platinum ® PCR Supermix 
(Supermix) or High Fidelity Platinum ® PCR Supermix (HIFI Supermix) (Invitrogen). 
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT). 
Restriction enzymes used were acquired from New England Biolabs Inc., and used as 
indicated by the manufacturer. DNA purification from agarose was routinely performed 
using a QIAquick Gel Extraction Kit (Qiagen) The QiaPrep Spin Miniprep Kit (Qiagen) 
was used for plasmid DNA extraction from E. coli. Purification of PCR products was 
performed using the MinElute PCR Purification kit (Qiagen) using a centrifuge. Real-time 
quantitative PCR was preformed with a 7500 Fast Real Time PCR System (Applied 
Biosystems). For E. coli cloning, T4 DNA ligase (Invitrogen) and corresponding buffer 
was normally used, as directed by the manufacturer. 
 
Transformation 
Transformation was used in mutant generation and as a measure of competence 
using a modification of a previously described transformation assay (136). In this, 50 μl of 
overnight cultures of each strain were diluted in 10 ml of prewarmed THHS and incubated 
at 37°C until reaching an OD660 of approximately 0.07. For assessment competence 
aliquots of 330μl were added to prewarmed 0.7-ml microcentrifuge tubes containing ± 70 
ng synthetic S. sanguinis CSP (59) and 10 ng pJFP16 (156), a suicide plasmid encoding 
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chloramphenicol (Cm) resistance, and incubated at 37°C for 60 to 90 min.   When multiple 
strains were assessed simultaneously, as in late com strains, DNA ± 70 ng was added to 
strains at 2 h, OD was noted and incubation was increased to 3 h for greater sensitivity. 
Dilutions were then drop-plated (105) on BHI agar plates and enumerated. During 
competence assessment, transformation frequency was measured following 48 h 
incubation as total CFU/ ml on BHI plates containing Cm divided by total CFU/ml from 
plates with no antibiotic. The effect of CSP on viability was measured as CFU/ml of cells 
incubated with CSP divided by CFU/ml of cells incubated without CSP. 
 
Creation of S. sanguinis mutant strains  
comCDE 
Deletion of the comCDE operon was performed using an overlap extension PCR 
technique (65), in which the comCDE operon was replaced with the aad9 Scr cassette of 
pR412 (101). Three separate PCR reactions were performed. The comCDEup1 and 
comCDEdn2 primers were used for amplification of the 1-kb region upstream of comCDE, 
the comCDEup3 and comCDEdn4 primers for the aad9 cassette, and the comCDEup5 and 
comCDEdn6 primers for the 0.8-kb region downstream from the operon (See Table 2).  In 
these reactions, primers were designed to create 25-bp regions of complementarity between 
the 3’ end of the upstream region and 5’ end of the aad9 cassette, and between the 3’ end 
of the aad9 cassette and the 5’ end of the downstream region. A fourth PCR using primers 
comCDEup1 and comCDEdn6 fused the three PCR products. All reactions were 
performed using a high-fidelity polymerase Supermix (Invitrogen). The 2.5-kb PCR fusion 
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product was column-purified (Qiagen, Inc. Valencia, CA) and used to transform SK36, 
with Sc selection. DNA sequencing confirmed that the mutant, JFP49, contained the 
desired comCDE deletion and Scr cassette insertion, and had no mutations within the 
flanking regions. 
comX   
The comX gene was replaced with the Knr cassette aphA-3 (144) using a novel, 
long-primer approach. Briefly, the aphA-3 gene was amplified with using 90-nt primers, 
comXkanF and comXkanR, (See Table 2).constructed to possess 15-nt 3' ends 
complementary to aphA-3 and 75-nt 5' ends complementary to the regions immediately 
upstream and downstream of comX.  The PCR product was purified as above and used to 
transform SK36, with selection for Knr. DNA sequencing confirmed that the mutant, 
JFP45, contained the desired cassette insertion and no mutations within the flanking 
regions.  
comXcomC 
A comXcomC mutant was constructed by amplifying the mutant comX locus from 
JFP45 cells with comXcomCF3 and comXcomCR4 to create a PCR product containing the 
aphA-3 cassette and approximately 200 bp of upstream and downstream flanking 
sequences amplified from the chromosome.  The product was then purified and used to 
transform the comC mutant, JFP41.  DNA sequencing confirmed that the mutant, JFP60, 
contained the desired cassette insertion in place of comX and no mutations within the 
flanking regions.  
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SSA_1889  
Mutagenesis of SSA_1889 was performed similarly to the comCDE mutation, 
where the products of three separate PCR reactions were combined. 1889up1 and 1889dn2 
were used to amplify the 0.9-kb region upstream of SSA_1889, the 1889up3 and 1889dn4 
primers amplified the aad9 (101) cassette, and the 1889up5 and 1889dn6 amplified the 
0.9-kb region downstream of SSA_1889.  In these reactions, primers were designed to 
create 25-bp regions of complementarity between the 3’ end of the upstream region and 5’ 
end of the aad9 cassette, and between the 3’ end of the aad9 cassette and the 5’ end of the 
downstream region. A fourth PCR reaction using 1889up1 and 1889dn6 fused the three 
products together. The 2.5-kb PCR fusion product was column-purified (Qiagen, Inc. 
Valencia, CA) and used to transform SK36, with Scr selection. DNA sequencing confirmed 
that the mutant, JFP65, contained the desired SSA_1889 deletion and Scr cassette insertion, 
and had no mutations within the flanking regions.  
A double SSA_0195 and SSA_1889 mutant, JFP61, was also constructed by 
transforming Ssx_0195 (23) (Knr) with the 2.5-kb purified PCR product used for JFP65 
construction with Scr and Knr selection.   
 
Additional Mutant strains 
Strains listed in Tables 3 and 4 were obtained from the laboratory of Dr. Ping Xu 
(Xu, et al manuscript under review) in BHI containing 500 μg/ml Kn (BHIKn500) and 
frozen in 30% glycerol and stored at -80°C. Each mutant was constructed using overlap 
extension PCR (65) to replace the respective ORF with the kanamycinR cassette aphA-3 
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(144). In these mutants, the first 6 and last 30 base pairs of the respective ORFs were 
maintained to sustain expression of flanking genes. 
 
Creation of a construct for controlled expression of SSA_0195 
The SSA_ 0195 gene was placed under the control of the isopropyl-beta-D-
thiogalactopyranoside (IPTG)-inducible promoter Pspank (17, 158) within plasmid pDR110 
(a kind gift from David Rudner, Harvard Medical School, Boston).  Directional cloning 
was used to insert PCR-amplified SSA_0195 and its native RBS into vector pDR110 via 
unique 5’ SalI and 3’ SphI sites to create pJFP93. An EcoRI/BamHI fragment containing 
the Pspank promoter, SSA_0195, and lacI from pJFP93 was ligated into the EcoRI/BamHI 
sites of the E. coli-streptococcal shuttle vector pVA838 (100) to create pJFP94.  pJFP94 
was used to transform Ssx_0195 and JFP41, employing selection for resistance to Kn plus 
Em or Em, respectively. To monitor the effect of SSA_0195 gene-overexpression, IPTG 
was added at concentrations ranging from 0 to 1000 μM. 
 
comXcomC electroporation with pJFP94 and pVA838 
 Electroporation of the comXcomC mutant was performed as previously described 
for Streptococcus parasanguinis (42) with modifications.  An overnight culture of JFP60 
was diluted 1:10 in TH broth and grown to OD660 ≈ 0.9. The culture was then harvested by 
centrifugation and resuspended in 10 ml 0.625 M sucrose, 10mM Tris-Cl, pH 6, followed 
by an additional centrifugation and resuspension in 1 ml 0.625 sucrose 10mM Tris-Cl, 
pH5.  An additional centrifugation occurred at 4° C followed by resuspension in 
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electroporation buffer (1 mM Tris-Cl, pH5). 50 µl aliquots of cells plus DNA (20 ng 
pJFP94 or pVA838) were electroporated in a 0.2 cm cuvette in a BioRad Gene Pulser set at 
2.5 kV, 25 mFD, 200 Ω. Cells were immediately transferred to recovery media (TH broth 
supplemented with 0.625 M sucrose) and incubated for 2h at 37°C.  Cells were plated 
employing selection for resistance to Kn plus Em. 
 
 
 
   
 30
Table 2. Primers used in this study for mutant generation 
 
Primer Nucleotide sequence ( 5' to 3')a  
comCDEup1 CCTCCTTGAATTACAATTGATG 
comCDEdn2 GGATCCACTAGTTCTAGAGCGGAACTATCTCCTATCTTTTTATCTT 
comCDEup3 AAGATAAAAAGATAGGAGATAGTTCCGCTCTAGAACTAGTGGA 
comCDEdn4 TTCCATTATATCAGGTTTCAATTTTTTTATAATTTTTTTAATCTG 
comCDEup5 CAGATTAAAAAAATTATAAAAAAATTGAAACCTGATATAATGGA 
comCDEdn6 AGCTGGCTATTTCAGTCAAAGTC  
1889up1 GAACACTCAAATCGCCAAATCT 
1889dn2 GGATCCACTAGTTCTAGAGCGGCAGGATAAAAAATAATCCCTTAG 
1889up3 CTAAGGGATTATTTTTTATCCTGCCGCTCTAGAACTAGTGGATCC 
1889dn4 GGATAAAAAATGACATTTCACAATTTTTTTATAATTTTTTTAATCTG   
1889up5 AGATTAAAAAAATTATAAAAAAATTGTGAAATGTCATTTTTTATCCC 
1889dn6   TCAGACGCTGAAGCTCTTGCCTG 
comXkanF GCTTTTTAGAAGAAAGAGCCCACCTTGCTTTCTATTTACAGTAGAAT
TAAGTCAAGTAAATTTTAAGGAGGAACTAAGGGCCCGTTTGAT 
comXkanR TTTTTATTTAATAAAAAAACTTGATGCTCTAACCTGTTCTAGTAAAA
CAGAAATAAAGTCATCAAGTTTGTTCACCGAATTCTAGGTACT 
comXcomCF3 TTTTTCTTGCTTTTATACTTCGC 
comXcomCR4 CCACTGACAGATTTATTTCTCGT 
0195SalIF CGCGCGTCGACTAAGAGAAGAATGGAGAGAATA 
0195SphIR GGTACGCATGCCACAAGAAGACCTTATCTAGT 
a Restriction sites denoted in bold; SalI, GTCGAC; SphI, GCATGC 
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Assessment of full length S. sanguinis ComC in competence induction 
 Full-length S. sanguinis ComC peptide (Fig. 2) was synthesized (Genscript) and 
used for assessment of genetic transformation in JFP41 relative to S. sanguinis CSP.  The 
ComC peptide was added to a transformation reaction as described above at an equimolar 
concentration to S. sanguinis CSP and compared to transformations with 220 ng/ml 
synthetic CSP. 
 
Growth studies  
Growth in broth culture was monitored as previously described (156).  Overnight 
cultures of strains were diluted 100-fold into THHS ± 220 ng/ml CSP. Strains containing 
plasmids pJFP94 or pVA838 were grown in THHS with Em and 125 µM IPTG ± CSP.  
Two hundred microliters of diluted cells of each strain were added in quadruplicate to the 
wells of a 96-well microtiter plate (Greiner). Growth at 37°C under ambient air was 
measured as OD450 in a FLUOstar microtiter plate reader (BMG technologies) every ten 
minutes immediately following orbital shaking.  Values indicated were obtained from 
subtraction of background wells.    
 
Bioassay for CSP quantification 
  SK36 cells were grown to various culture densities in TH-BSA (97) from early 
exponential to stationary and supernatant from each sample was collected following 
centrifugation at 7000 X g for 10 min at 4°C and filtration through a 0.22 μm filter. 
Supernatants were then added along with transforming DNA to comC mutant cells, which 
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are incapable of producing CSP. Transformations performed with synthetic CSP were used 
to create a standard curve for quantification of CSP in supernatant. 
 
Isolation and mass determination of CSP from SK36 cultures 
Isolation of CSP from culture supernatant was performed using modifications of a 
previously described method used in S. pneumoniae (56). SK36 and control, JFP41, were 
grown overnight in TH (0.15% BSA) (97). The next morning strains were diluted 1:200 
and grown to OD660 of 1.10.  Cells were then pelleted by centrifugation at 7000 X g for 10 
min at 4°C and supernatant was filtered using 0.22 μm SteriCups® (Millipore).  20 ml 
aliquots of the filtered supernatant were rocked for 18 hr with 40% (NH4)2SO4 at 4° C.  
Precipitated proteins were then pelleted by centrifugation at 10,000 X g for 30 minutes and 
dissolved in 1ml HPLC water (FisherBrand).  Total protein concentration was determined 
by Pierce assay and functionality of CSP within protein sample was tested by bioassay as 
described above. Samples from both strains were sent to the Mass Spectrometry core 
facility at Virginia Commonwealth University.  They underwent 2-D dimensional analysis 
with strong cation exchange fractionization and liquid chromatography mass spectrometry 
using collision induced dissociation (CID) (107) in ion trap of the fractions. The sample 
was searched against an S. sanguinis protein database, allowing for cleavage anywhere 
within the ComC peptide. 
 
 
 
 
 
   
 33
High-throughput ABC exporter mutant competence assay. 
 
  For high throughput analysis of competence, microtiter plates containing frozen 
stocks were thawed on ice and 2 μl of each strain was inoculated into 2 ml of THHS a 
sterile polypropylene deep well plate (USA Scientific), sealed with Qiagen tape pads, and 
incubated O/N at 37° C.  The next morning all strains were diluted 1:200 (1.6 μl  cells 
added to 330 μl THHS) in duplicate deep well plates containing prewarmed THHS and 
10ng of pJFP16, covered with Airpore Tape sheets (Qiagen) and incubated at 37°C. After 
1.5 hr, 70 ng of CSP was added to one plate. Plates were then returned to 37°C for 5 
additional hours to ensure cells reached the proper optical density for DNA uptake and 
sufficient time for incubation with DNA. 10 μl of each strain were then added to deep well 
plates containing 990 μl BHI ± Cm, covered with Airpore Tape sheets and incubate at 6% 
O2. The following morning growth was measure at OD450 in a FLUOstar microtiter plate 
reader (BMG technologies). Media background was subtracted and mean OD450 for each 
strain was measured. 
 
Rabbit model of infective endocarditis   
Virulence assays were performed using a modification of a previously described 
rabbit aortic valve endocarditis model, using male specific pathogen-free New Zealand 
White rabbits weighing from 3 to 4 kg (34).  All protocols were performed in accordance 
with Institutional Animal Care and Use Committee, and in compliance with all federal 
guidelines and institutional policies. Prior to surgery, animals were sedated with 
acepromazine, anesthetized with a cocktail of ketamine, xylazine, glycopyrrolate, and 
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buprenorphine, and injected with bupivacaine at the incision site.  A catheter was then 
inserted over the aortic valve via the right carotid artery to induce vegetation formation 
(34), as described previously (25, 47, 122, 156, 157) The catheter was then sutured and 
kept in place for the remainder of the study.  All efforts were made to ameliorate suffering 
of animals at all stages of the experiment. Buprenorphine was provided as analgesia twice 
daily throughout the study. 
 
Competitive index analyses in the rabbit model of IE 
To prepare inocula, bacterial strains were grown for 18 hours in BHI, and diluted 
10-fold into BHI for an additional 3 h of growth at 37° C. Cells were then harvested, 
washed in PBS, and diluted to the appropriate cell density, followed by inoculation of 0.5 
ml into a marginal ear vein. Inoculations were performed two days post-catheterization. 
Dilutions of the inocula were drop-plated onto BHI agar, with selective antibiotic when 
required, and enumerated. After specified infection periods, rabbits were euthanized by 
intravenous Euthasol (Virbac AH, Fort Worth, TX) injection. Vegetations, which were 
readily identified as rough nodules or masses, were collected at pre-determined times from 
aortic valves and endocardium and homogenized in PBS. Dilutions were drop-plated for 
bacterial enumeration.  
 During competitive index (CI) experiments, JFP45 or JFP49 was co-inoculated 
with an Emr derivative of SK36, JFP36 (156), and the strains were co-cultured for 3 h prior 
to washing and suspension in PBS, as described above and plated on selective antibiotics. 
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The CI value for each rabbit was calculated as the ratio of mutant/JFP36 in the vegetation 
homogenate divided by the mutant/JFP36 ratio in the inoculum.  
Individual inoculum analyses in the rabbit model of IE 
 For experiments employing inoculation of individual strains, inocula were prepared 
as described above, except that strains were cultured individually, randomized for 
individual inoculation into four catheterized rabbits each, and sonicated prior to inoculation 
at 50% power for 3 minutes using a titanium cup adapter (BioLogics Inc.) Following 
sonication, cells were adjusted to an OD660 value determined previously to correspond to 
108 CFU/ml. During the course of infection, rabbits were weighed daily.  
 Five days post-inoculation, ~ 10 ml of blood was drawn from an ear artery of 
surviving rabbits using a blood collection set (BD, Franklin Lakes, N.J.; cat. no. 368653) 
and blood culture tubes containing 1.7 ml of 0.35% sodium polyanethol sulfonate solution 
(BD; cat. no. 364960). Rabbits were immediately sacrificed, necropsy was performed, and 
valve vegetations were weighed prior to homogenization and sonication. Density of 
infection was determined as CFU/g of vegetation. Blood densities were determined by 
mixing 10 μl to 1 ml of blood with 20 ml 1% low-melting agarose in BHI, which was then 
poured into Petri dishes, allowed to harden, and incubated for two days at 37°C prior to 
counting of colonies on triplicate plates. Blood density values were corrected to account 
for the added sodium polyanethol sulfonate.  The entire experiment was then repeated on a 
separate occasion, and the results combined. 
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Assessment of biofilm formation with crystal violet staining 
The crystal violet (CV) biofilm assay (118) was performed as previously described 
(47), with minor modifications.  Briefly, cells were grown in BHI with respective 
antibiotics overnight. Cells were then diluted 1:10 into pre-warmed BHI for 3 hours of 
additional growth, followed by transfer of 1 µl to individual wells of 96-well polystyrene 
microtiter plates (Greiner) containing 100 µl Biofilm Media (BM) (SAFC Biosciences, 
Lenexa, KS) supplemented with 1% sucrose ± 220 ng/ml synthetic S. sanguinis CSP. 
Biofilms then developed for 20 hours with no shaking anaerobically. Planktonic cells were 
then decanted from wells, and biofilms were rinsed twice with 200 µl sterile distilled 
dH2O. Plates were then dried at room temperature. Twenty-five µl of 1% (w/v) crystal 
violet (CV) was added to each well and incubated for 15 min. The plates were then washed 
three times with 200 µl dH2O.  The stain was solubilized in 30% (v/v) acetic acid and 125 
µl was transferred to a new microtiter plate where absorbance was read at 600 nm. The 
OD600 was determined as the mean ± SD from three independent assays, with each strain 
tested in quadruplicate wells.  To examine the role of extracellular DNA during biofilm 
formation, DNase I (Sigma) was added to the BM media immediately prior to inoculation.   
 
Confocal Laser Scanning Microscopy (CLSM) 
Strains were grown as for CV staining except that COSTAR 60-mm polystyrene 
plates (Falcon-Primaria) were used in place of microtiter plates, and volumes were 
adjusted proportionally. At 20 h, planktonic cells were removed and biofilms washed twice 
with sterile dH2O.  Biofilms were then stained for 15 min with a 1:1000 dilution of 
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Invitrogen LIVE/DEAD® BacLightTM bacterial viability reagent, containing SYTO9 and 
propidium iodide; stain was then removed and biofilms were covered with sterile dH2O. 
Biofilms were visualized using a 40x water-immersion dipping objective on a Zeiss LSM 
510 META confocal laser scanning microscope. Excitation wavelengths used were 488 nm 
for SYTO 9 and 561 nm for PI. Images were examined using LSM image software (Carl 
Zeiss).  
 
Scanning Electron Microscopy (SEM)   
Biofilms were prepared as for CLSM, except that a glass coverslip (Fisherbrand) 
was immersed in the COSTAR 60-mm polystyrene plates. After 20 h, the coverslips were 
rinsed in sterile water and fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer (cb), 
followed by fixation with 0.1% osmium tetroxide and an additional rinse in cb. 
Dehydration was performed with a series of ethanol rinses at 50%, 70%, 80%, 95% and 
100% followed by three hexamethadisilizane changes. Samples were dried in fume hood 
and mounted on SEM stubs with silver paint, allowed to dry overnight, and gold coated 2-3 
times prior to viewing. Samples were viewed on a ZEISS EVO 50 XVP Scanning Electron 
Microscope.   
 
Quantitative RT-PCR of SSA_0195  
JFP41 was grown to an OD660 ≈ 0.070 in THHS. 12.5 ml of culture was mixed with 
Twenty five mls of RNAprotect (Qiagen) and vortexed briefly. CSP was added to the 
remaining culture at a concentration of 220ng/ml.  Additional samples were collected at 
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2.5, 5, and 15 minutes post-CSP induction and similarly mixed with a 2 volumes of RNA 
protect. Extraction proceeded as described in the manufacture’s protocol for gram positive 
bacteria with a few modifications.  After stabilizing cultures in RNA protect cultures were 
incubated for five minutes at room temperature and centrifuged for 20 minutes at 8,000 x g 
for 20 minutes.  The resulting pellet was resuspended in 100µl of TE buffer containing 15 
mg/ml lysozyme and 2 mg/ml proteinase K and incubated with frequent vortexing for 30 
minutes.  After addition of lysis buffer, cells were lysed at a setting of 6 for two cycles at 
55 seconds each in lysing matrix B (MPBio) using a beadbeater (MPBio) followed by 
purification via the Qiagen RNeasy Mini Kit, during which Dnase I treatment occurred for 
30 minutes over RNeasy Columns (Qiagen).  Samples were quantified at 260 nm and 
samples with a 260/280 ratio >2.2 or <1.8 were discarded. RNA samples were stored at -80 
°C.  Samples were further analyzed using an Experion TM Chip (Biorad) and RNA was 
stored at -80°C. Additional treatment to remove genomic DNA was performed with 
TurboFree (Ambion) using manufacturer’s instructions. 
First strand cDNA synthesis occurred in a 20 µl reaction using 1.1µg total RNA 
annealed to 250 ng random primers and incubated with 10mM dNTP mix for 5 minutes at 
65 °C. Brief centrifugation of the tube was performed and First Strand Buffer (Invitrogen), 
1 µl 0.1 M DTT, 1 µl RNAse OUT (Invitrogen) and 1 µl Super Script III Reverse 
transcriptase (200 units/µl) (Invitrogen) were added. The mixture was gently pipetted up 
and down incubated for 5 minutes at 25°C, followed by sixty minute incubation at 60 °C. 
Reactions lacking reverse transcriptase were also prepared simultaneously to test for 
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genomic DNA contamination.  Inactivation of reverse transcriptase proceeded for 15 
minutes at 70°C. 
qRT-PCR reactions were performed using a 7500 Fast RT-PCR system (Applied 
Biosystems). 10 μ qRT-PCR reactions were carried out in a using Real- TimeTM SYBR 
Green/Rox PCR master mix (SuperArray) and internal designed primers in list appendix. 
SSA_0195 was selected for RT-PCR quantification to The gapA gene was used for 
normalization. A standard curve for SSA_0195 and gapA was generated using serial 
dilutions of DNA templates of known concentration. Values were then normalized and 
relative expression levels were determined through comparison of mean quantity of 
transcript levels to control. 
 
Statistical Tests  
All statistical tests were performed using InStat (GraphPad Software Inc.), with α = 
0.05. Actual P values are indicated in the text and figure legends. For virulence assays, 
log-transformed CI values were compared to 0 using a one-sample t test. Strain recoveries, 
infection densities, vegetation masses, and weight loss for each strain group were 
compared using one-way ANOVA. Survival rates were compared by Kaplan-Meier 
analysis. Significance of differences in CV staining, culture densities, transformation 
assays, and CSP viable counts were assessed using paired t tests. 
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 CHAPTER 3: CHARACTERIZATION OF GENETIC 
COMPETENCE IN STREPTOCOCCUS SANGUINIS 
 
 
RATIONALE 
Despite the apparent absence in S. sanguinis of the comA, comB, and comW genes 
(168), physiological studies and global expression analyses have demonstrated that S. 
sanguinis competence and com gene regulation are similar in most respects to that of S. 
pneumoniae (136). Microarray studies performed with a comC mutant suggested 
upregulation of 124 genes in S. sanguinis in response to CSP (136). In S. pneumoniae 
(131) microarray analysis identified a similar, though non-identical set of CSP-upregulated 
genes. Among the major differences observed were the significantly fewer “early” genes 
within S. sanguinis (136).  Early response com genes identified in S. sanguinis by 
microarray were comCDE and comX, and a previously uncharacterized gene, SSA_1889. 
The “late” genes identified were representative of those seen in other studies (131, 136, 
161).  In contrast to the other streptococci, the sequence of the S. sanguinis ComC peptide 
is unique in that it lacks the Gly-Gly motif that serves as the site of cleavage for CSP 
formation in other ComC peptides. Additionally, the secretion apparatus has not been 
identified.  Here we seek to further characterize features of the S. sanguinis com regulon 
including functions of the early and late com genes, and mechanisms of ComC processing. 
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RESULTS 
Creation and verification of early com mutants in S. sanguinis  
To examine possible functions of the S. sanguinis com regulon, we first sought to 
create mutations in key regulatory genes. We used an overlap extension PCR technique 
(65) to fuse a Scr cassette to ~1 kb of DNA on either side of the comCDE operon. 
Introduction of this construct into SK36 resulted in the replacement of the comCDE genes 
with the Scr cassette, creating mutant JFP49. (See Table 1 for strains and Table 2 for 
primers.)  Mutation of the comX gene by the same strategy was problematic because the 
gene is closely flanked by tRNA genes on one side and a 16S rRNA gene on the other 
(168). To avoid transforming with a construct containing these repetitive sequences, we 
attempted the novel approach of amplifying a Knr gene (144) with PCR primers designed 
with 75-nt 5’ ends complementary to comX-flanking sequences, and then introducing the 
purified product into SK36 by transformation. Although the transformation efficiency was 
low, we succeeded in isolating a mutant, JFP45, in which the comX gene was replaced by 
the Knr cassette. 
 We then tested both mutants and a comC mutant in transformation assays in the 
absence and presence of S. sanguinis CSP. The transforming DNA, plasmid, pJFP16, (Fig. 
3A) is a suicide plasmid encoding a chloramphenicol acetyltransferase (cat) gene within a 
mini-transposon flanked by approximately 1.9 kb of DNA encoding and flanking the S. 
sanguinis nrdD gene (156). We expected that a previously created comC mutant would be 
incapable of CSP secretion and would only be transformed when synthetic CSP was added 
to the media. This result was observed (Fig. 3B), lowering the frequency from 11% in the 
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presence of CSP to below the limit of detection in the absence of CSP (3.6% X 10-5 %). 
We expected that the comCDE mutant would not undergo transformation in either the 
presence or absence of added synthetic CSP, as loss of the CSP sensor and its cognate 
response regulator would not be overcome by the addition of CSP (131). As expected, 
mutation of comCDE drastically reduced or eliminated transformation (Fig. 3), lowering 
the frequency from 12% in SK36 to below the level of detection (1.3 X 10-5 %) in JFP49 in 
both the presence and absence of CSP. Similarly, we expected a comX mutant to exhibit 
little or no competence in the presence or absence of CSP, as the sigma factor it encodes is 
required for upregulation of DNA uptake genes in other species (131). Comparable results 
were obtained; deletion of comX lowered the transformation frequency from 12% in SK36 
to below the limit of detection (7.7 X 10-5 %) in JFP45, in the presence or absence of CSP. 
The combined results suggest that these four genes function in S. sanguinis competence 
regulation indistinguishably from their counterparts in S. pneumoniae (131), S. gordonii 
(161), and other Mitis group species (102).   
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Figure 3. Transformation of strains possessing mutations in early com genes 
 
A. Plasmid map of transforming DNA, pJFP16 (Reproduced with permission) 
 
B. S. sanguinis strain SK36 and its isogenic mutants were assayed for transformation 
frequency defined as the ratio of Cmr transformants to total colony forming units (CFUs). 
Shown are the transformation frequencies ± SD of three independent experiments.  
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Figure 3. 
 
A. 
 
B. 
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 Identification of SSA_0195 as an early gene 
A previous microarray study (136) in this lab performed with the comC mutant, 
JFP41, revealed an additional gene that exhibited kinetics consistent with early gene 
expression, appearing upregulated by CSP more than 15-fold at 2.5 min and more than 
four-fold at all later time points, but failed the significance test due primarily to 
undetectable expression at time 0 (Fig. 4).  Expression of this gene, SSA_0195, was 
therefore examined by quantitative RT-PCR, using gapA for normalization. SSA_0195 
expression at time 0 was barely detectable. In comparison, mean normalized log2 values 
for expression of SSA_0195 at 2.5, 5, and 15 min post-CSP addition were 32.6, 36.1, and 
30.6, respectively, indicating strong and rapid induction. Inclusion of SSA_0195 along 
with the missing comC gene suggests a total of six early genes: comCDE, comX, 
SSA_1889, and SSA_0195. 
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Figure 4. Colorimetric map of S. sanguinis early com genes   
(Reproduced with permission)  
 
Each column represents the time point indicated above, and each row the expression of a 
single gene relative to the “0” time point, as measured by microarray analysis. Levels of 
gene upregulation in response to CSP are indicated by colors varying from black (<2 fold) 
to bright red (>32 fold). Gray squares indicate incomplete data. Genes in red text are 
homologs of early competence genes from S. pneumoniae.  
 
A. Represents initial analysis.  
 
B. Represents final analysis after significance test. SSA_0195 was filtered out due to 
extremely low expression at T0. 
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Figure 4. 
 
A. 
 
 
 
B. 
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Screening of early genes as potential ComC exporters 
 
Because no comAB-like genes were identified during sequencing (168), one goal of 
this study was to identify orthologs (or analogs) of the S. pneumoniae ComA and ComB 
CSP transporters. Based on the finding that both are encoded by “early” genes in S. 
pneumoniae (131) and S. gordonii (161), this lab originally used a transcriptome analysis 
for this search. As mentioned above, microarray and RT-PCR revealed six “early” genes 
whose expression was upregulated at least 4-fold at 2.5 minutes post-CSP. Three were 
known early com genes: comD, comE and comX. The two additional genes were 
SSA_0195 and SSA_1889. Both genes encode hypothetical proteins. SSA_1889 is 
annotated as a conserved uncharacterized protein. Apart from alleles in other S. sanguinis 
genome-sequenced strains, its closest match in GenBank is a hypothetical protein from S. 
anginosus (ZP_08014095.1). SSA_0195 is annotated as a hypothetical protein whose 
closest matches are also alleles from other S. sanguinis strains, followed by a hypothetical 
protein from Streptococcus cristatus (ZP_08059937.1).  Both proteins have weak 
homology to the CAAX family of N- terminal proteases, (124) yet possess no significant 
similarity to each other. We hypothesized that one or both of these was involved in CSP 
secretion or otherwise required for genetic competence. SSA_0195 and SSA_1889 mutants 
and a double mutant were constructed by an overlap extension PCR technique (65) and 
tested for competence, using pJFP16 as described. We would expect that a transporter 
mutant would be severely reduced for transformation, except in the presence of exogenous 
CSP. However none of the three mutants exhibited a greater than two- fold reduction in 
transformation in either the presence and absence of CSP, suggesting that neither gene 
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encodes a CSP transporter or any other function critical for transformation (data not 
shown).  
 
Assessment of “late” com genes in S. sanguinis 
We next assessed competence in orthologs of late genes identified in S. sanguinis 
(168) found previously to be required for transformation in S. pneumoniae (131). Many of 
these genes were identified in a previous microarray study within our lab, to be 
upregulated in response to CSP (136).  However, this study failed to identify the 
upregulation of 5 orthologs of late genes found previously to be required for 
transformation in S. pneumoniae. We next wished to determine if this was due to a 
fundamental difference in transformation machinery in the two species. We took advantage 
of an existing collection of SK36 allelic exchange mutants in which genes were replaced 
by the aphA-3 gene encoding kanamycin resistance (Xu et al., manuscript in preparation) 
to test the effect on the transformation efficiency of mutating 15 genes that were either 
orthologs of genes essential for transformation in S. pneumoniae, or were located in the 
same gene cluster. Those tested included orthologs of each of the 5 genes whose 
upregulation was not detected. Transformation was assessed in SK36 and the mutants as 
above, except that the incubation with CSP and DNA was begun at a lower OD and 
extended to two hours for increased sensitivity, and surface plating was used. The results 
are presented in Table 3 and were comparable in comparison to their orthologs in S. 
pneumoniae (131).   
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Table 3.  Assessment of competence in late com orthologs in S. sanguinis  
Orthologs of putative “late gene” mutants in S. sanguinis were assessed for 
competence. Gene list indicates allelic mutants. % of WT is transformation 
frequency of mutant divided by transformation frequency of SK36. Each gene is 
listed in the same row as its S. pneumoniae ortholog, and competence in S. 
pneumoniae mutant strains determined previously is listed (131).  In S. 
pneumoniae, transformation in mutant is indicated as “Y” for yes or “N” for no. 
Percentage indicated equals percent of WT.  
This experiment was performed in triplicate and mean frequencies are indicated. 
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Consideration of potential ComA-independent ComC secretion mechanisms in S. 
sanguinis  
 
As discussed, sequencing of S. sanguinis revealed a unique ComC (Fig. 2) 
sequence with no ComA ortholog or analog identified through DNA sequencing or 
microarray analysis (136, 168). We next considered the possibility that ComC is exported 
without cleavage in S. sanguinis, perhaps by a non-specific transporter. If this were the 
case, we might expect full-length ComC to have greater competence-stimulating activity 
than our CSP peptide. A full-length ComC peptide was synthesized by GenScript. Genetic 
transformation of the comC mutant was tested as described above using pJFP16 ± 70 ng 
CSP, or an equimolar concentration of full-length ComC. As seen in figure 5, we observed 
15-fold greater transformation frequencies using CSP compared to the full-length peptide. 
These results, though far from conclusive, suggest that ComC is cleaved in S. sanguinis.  
Finally, we also considered the possibility that ComC is processed through the 
standard Sec-dependent pathway. Several bacteriocins have been shown to be similarly 
processed (64, 89), However, in contrast to these bacteriocins, which have typical signal 
peptide sequences, analysis of ComC by SignalP 3.0 (36, 116) identified no hint of a signal 
sequence (Fig.6) and classified this peptide as a non-secretory protein.  
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Figure 5. Transformation comparisons of full length ComC and processed CSP   
 
JFP41, the comC mutant, was assayed for transformation frequency using the standard 70 
ng of synthetic CSP or an equimolar (162 ng) full length ComC peptide.  
 * indicates significant variation from full length peptide transformation frequency (P < 
0.0001).  
Shown are the transformation frequencies ± SD of two independent experiments.  
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Figure 5.  
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Figure 6. SignalP Cleavage Prediction analysis of:  
 
(A) Lactococcus lactis bacteriocin lactoccin, where cleavage is predicted to occur between 
amino acid positions 25 and 26 
 
(B) S. sanguinis ComC  
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Figure 6.  SignalP Prediction for:  
A.  Lactococcus lactis bacteriocin lactococcin 
 
B.  S. sanguinis ComC 
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Determination of ideal culture density for CSP isolation 
Given the possibility that ComC is cleaved to CSP when exported, we next wished 
to determine the sequence of secreted SK36 CSP.  We first determined that BSA could 
replace horse serum in TH-HS without decreasing the transformation efficiency of the 
SK36 strain (data not shown).  BSA has been used previously as a substitute for serum in 
streptococcal transformation (97) and will likely contain fewer peptides that could interfere 
with CSP isolation (Gunnar Fimland, personal communication). To determine the culture 
density containing the greatest amount of CSP, SK36 cells were grown to various culture 
densities in TH-BSA, and culture supernatant from each sample was collected following 
centrifugation and filtration through a 0.22 μm filter. 20 μl from each supernatant were 
then added along with pJFP16 to JFP41, comC mutant cells, which are incapable of 
producing CSP. As a control, supernatant from a comC mutant was similarly added and did 
not induce competence (data not shown).  Although transformation efficiency of SK36 
peaks at an OD660 of ~ 0.07, (136) Fig. 7 shows that the culture supernatant from stationary 
phase cells had much higher levels of competence-stimulating activity than cultures 
harvested during the peak of competence. Transformations were then performed with 
synthetic CSP to create a standard curve to quantify CSP in supernatant.  Using linear 
regression we determined there was approximately 1.2 ng of CSP in each μl of supernatant 
taken from a culture with an OD660 of 1.1.  
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Figure 7. Competence induction in a comC-deficient strain using SK36 culture 
supernatants or synthetic CSP  
 
A. SK36 supernatants were collected at various densities and 20 μl used to induce 
competence in a comC-deficient strain incubated with transforming DNA (pJFP16). A 
representative experiment of three separate experiments is shown.  
 
B. Standard curve created by adding known concentrations of synthetic CSP to induce 
competence in a comC-deficient strain incubated with pJFP16. A representative experiment 
of three separate experiments is shown.  
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Figure 7. 
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Isolation of CSP from competent SK36 supernatant 
To increase the concentration of CSP in our sample, we next used ammonium 
sulfate precipitation of total secreted proteins. Preliminary experiments tested the 
transforming ability of centrifuged, filtered SK36 supernatants precipitated with 40% to 
70% (NH4)2SO4, and determined 40% contained the greatest amount of functional CSP.  
JFP41 was similarly treated and its culture supernatant did not induce competence (data 
not shown).  The precipitated culture samples from each strain were then dissolved in 
HPLC grade water, resulting in a final concentration of 20-fold. 
 Each sample then underwent 2-D dimensional analysis with strong cation 
exchange fractionization followed by liquid chromatography mass spectrometry (LC-MS) 
using CID fragmentation of the fractions.  The samples were then searched against an S. 
sanguinis protein database, allowing for cleavage anywhere within the ComC peptide. No 
matches were identified in the JFP41 sample. The practical fractionization spectra for 
SK36 is illustrated in Fig. 8. The identified secreted CSP had a +3 charge, with the original 
peptide mass to charge ratio identified at 590.6484 corresponding to a mass of 1769.92. 
Post-experiment Monoisotopic Mass Filtering (139) analysis determined the peptide mass 
matched to 3.3 ppm accuracy.  However, as seen in Fig. 8, using CID fragmentation often 
results in loss of the parent mass within the spectrum. There is, therefore, a hole in the 
spectrum occurring around 590 m/z (Kristina Nelson, personal communication).  Sequest 
analysis (39) was also performed, and determined a match corresponding to the last 15 
amino acids of ComC (DLRGVPNPWGWIFGR) (Fig. 9) with a cross-correlation (XCorr) 
value of 3.85, indicating a very good match.   
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Figure 8. Practical fragmentation spectra of SK36 CSP  
 
Practical fragmentation spectrum using collision induced dissociation of Liquid 
Chromatography Mass Spectrometry of secreted CSP from SK36 
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Figure 9.Theoretical fragmentation spectra of S. sanguinis CSP  
Theoretical fragmentation spectra using Sequest analysis of peptide sequence. Masses 
indicated represent singly charged fragments and predict the sequence of amino acids 
within analyzed peptide. 
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Candidate exporter selection and screen  
 
As discussed, ComA in other streptococcal species serves a dual function involving 
removal of a leader peptide from its substrate and transport across the plasma membrane. 
Findings so far within S. sanguinis suggest processing of ComC during transport; however, 
the mechanisms and the identity of the transporter remain uncharacterized. Further, 
microarray data suggested that the ComC exporter is not specifically up-regulated in 
response to CSP as in S. pneumoniae. We next considered the possibility that ComC is 
transported by an ABC exporter whose principle function is secretion of another small 
peptide or drug. Because ComA is capable of concomitant transport and cleavage (57), we 
next identified candidate systems possessing strong homology to this protein.  Within the 
genome of SK36 there are a total of 147 ABC transporters. Of these, the 26 ABC export 
systems listed in table 4 were selected as candidates that exhibit homology to systems 
capable of peptide and drug export. These systems were conserved in BlastP (5) searches 
of the SK36 genome against ComA of several S. pneumoniae strains, S. gordonii, NisT 
(40) and SpaT (76). NisT and SpaT are ABC transporters that transport nisin and subtilin, 
respectively, two bacteriocins lacking a double glycine cleavage signal, which is also 
missing in ComC. Within such bacteriocin systems, the transporter is often encoded on the 
same or nearby operon as the peptide.  Prior to the microarray study, previous work in the 
lab began this screen, noting such proximity.  SSA_2249, which exhibits homology to the 
ATPase component of small peptide transporters, was first tested as a potential ComC 
exporter.  This transport system is located two genes away from recA and cinA, two 
essential genes for transformation which are ComX dependent in S. pneumoniae (131). A 
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mutant was assayed for transformability.  However, it was readily transformable in both 
the presence and absence of synthetic CSP. We next continued our search of the exporter 
by testing genetic competence in all knockouts of these candidate systems.  
The candidate ABC permease and ATPase genes chosen were selected based upon 
putative transport classification (168) using the transport classification database 
(TCDB.org) (137). The types of exporters chosen exhibited strong homology to ABC-type 
transport systems which export lantibiotic bacteriocins (which lack a GG signal), non-
lanthionine bacteriocin (which contain GG cleavage motifs) (70) exporter systems 
involved in drug efflux and lastly, the alpha and beta toxin exporters. SSA_1100 is 
classified as an alpha-hemolysin exporter exhibiting the highest alignment scores of the 
ComA protein of S. pneumoniae, S. gordonii, and S. mutans against the SK36 genome.   
To determine if ComC is transported by an ABC exporter whose principle function 
is secretion of another small peptide or metabolite, we screened an existing mutant library 
for strains possessing the expected phenotype of a transport mutant, growth in Cm when 
provided pJFP16 in the presence of synthetic CSP, but not when CSP is omitted. As 
before, strains were obtained from the laboratory of Dr. Ping Xu, where the respective 
ORFs were replaced with an aphA-3 Knr cassette. The candidate systems selected 
encompassed approximately 60 genes and are shown in Table 4.  
This screen began by using plate transformations assays as described above, and  
mutants of SSA_1100, SSA_0201, SSA_0407, and SSA_0412 were tested that way, all of 
which were transformed in both the presence and absence of CSP (not shown).  To 
increase the number of mutants that could be tested at one time, we then employed a high-
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throughput liquid transformation assay as described in the methods. SK36 and JFP41 ± 
CSP were simultaneously tested as controls for wild-type and mutant competence, 
respectively.  The results of this screen are demonstrated in Fig. 10.  All strains grew in the 
presence of BHI (not shown).  As seen in Figure 10, JFP41 gave rise to Cmr transformants 
when incubated with transforming DNA in the presence of exogenous CSP but not in its 
absence. In contrast, SK36, which is capable of producing its own CSP, produced Cmr 
transformants in both the absence of presence of CSP. Neither strain was able to grow in 
Cm in the absence of DNA. The results of this high throughput analysis are shown in Fig. 
10, and indicate none of the mutants screened exhibited the desired phenotype of ComC 
exporter. Strains exhibiting variability in overnight optical density in media containing Cm 
between ± CSP incubations were further tested individually using plate transformations.  
However such analysis did not reveal any mutant with the desired phenotype (not shown). 
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Table 4. Candidate ComC export systems 
 
S. sanguinis ABC export systems selected to screen for processing and secretion of the 
propeptide ComC to the mature quorum sensing signal, CSP. Classification of these 
systems within SK36 is putative and based on strong homology to systems described in the 
Transport Classification Database (TCDB.org).  Those systems listed exhibit strong 
homology to: the lantibiotic bacteriocins exporters, the non-lanthionine bacteriocin 
exporters, the drug efflux systems and alpha and beta toxin exporters. Table 4 is split into 
A and B for clarity of presentation.  
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Table 4 A.  
 
Gene ID Description
SSA_0201 ABC multidrug transporter 3-component subtilin immunity exporter, putative
SSA_0202 Conserved hypothetical protein, possible transmembrane
SSA_0203 Conserved hypothetical protein, possible transmembrane
SSA_0407 Multidrug ABC transporter, ATPase and permease components, putative
SSA_0408 Conserved hypothetical protein
SSA_0410 Conserved hypothetical protein
SSA_0411 Conserved hypothetical protein
SSA_0412 ABC multidrug transporter (3-component subtilin immunity exporter, putative
SSA_1766 Bacitracin ABC transporter, permease protein, putative
SSA_1767 Bacitracin ABC transporter, ATP-binding protein, putative
SSA_2010 ABC-type multidrug transport system, permease component, putative
SSA_2011 ABC-type multidrug transport system, ATPase component, putative
SSA_0393 Bacteriocin ABC-type exporter, ATP binding/permease protein, putative
SSA_0722 Conserved hypothetical protein, possible membrane-associated peptidase
SSA_0723 Hypothetical protein
SSA_0724 ABC-type multidrug/protein/lipid transport system (pediocin PA-1 exporter)
SSA_0725 Hypothetical protein
SSA_0726 FmtA-like protein, putative
SSA_0727 Metal-dependent membrane protease, putative
SSA_0728 Protease, putative
SSA_0442 ABC-type multidrug transport system, ATPase component, putative
SSA_0443 Possible ABC-type efflux pump permease component, putative
SSA_0461 ABC-type multidrug transport system, ATPase and permease components
SSA_0462 ABC-type multidrug transport system ATPase and permease components
SSA_0607 ABC transporter, permease component, putative
SSA_0608 Macrolide-efflux protein, putative
SSA_0796 ABC-NBD transporters with duplicated ATPase domains, putative
SSA_0894 ATP-binding cassette protein, putative
SSA_0895 ATP-binding cassette transporter-like protein, putative  
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Table 4 B.  
 
Gene ID Description
SSA_0910 ABC-type multidrug transporter, ATPase component, putative
SSA_2165 ABC-type oligopeptide transporter, periplasmic component, putative
SSA_2166 ABC-type multidrug transporter, ATPase and permease components, putative
SSA_2167 ABC-type multidrug transporter, ATPase and permease components, putative
SSA_0928 ABC-type multidrug transporter, ATPase and permease components, putative
SSA_0929 ABC-type multidrug transporter, ATPase and permease components, putative
SSA_1026 ABC-type multidrug transporter, ATPase component, putative
SSA_1087 ABC-type transporter (antibiotic resistance protein), ATPase component, putative
SSA_1107 Multidrug/protein-type ABC exporter, ATP binding/membrane-spanning protein
SSA_1109 ABC transporter ATP binding/permease protein, putative
SSA_1373 ATPase components of ABC transporters, multidrug transport system
SSA_1374 Multidrug ABC transporter, ATPase and permease components, putative
SSA_1375 Multidrug ABC transporter, ATPase and permease components, putative
SSA_1376 Transport protein, putative
SSA_1402 ABC-type multidrug transport system, ATPase and permease components, putative
SSA_1403 Multidrug ABC transporter, ATPase and permease components, putative
SSA_1530 ABC-type antimicrobial peptide transport system, permease component, putative
SSA_1531 ABC-type antimicrobial peptide transporter, ATPase component, putative
SSA_1532 Membrane-fusion protein / periplasmic component of efflux system, putative
SSA_1636 ABC-type antibiotic exporter, ATPase component, putative
SSA_1658 Cationic amino acid transporter, putative
SSA_1659 ABC-type antimicrobial peptide transport system, permease component, putative
SSA_1660 ABC-type antimicrobial peptide transport system, ATPase component, putative
SSA_1679 ABC-type multidrug transport system, ATPase component, putative
SSA_1680 ABC-type bacitracin resistance protein A, permease component, putative
SSA_1681 ABC-type bacitracin resistance protein A, ATPase component, putative
SSA_1100 HylB ATPase of the RTX toxin export system, putative
SSA_1904 ABC-type multidrug transport system, permease component, putative
SSA_1905 ABC-type multidrug transport system, ATPase component, putative
SSA_2376 ABC transporter with duplicated ATPase domains, putative
SSA_2377 ABC transporter, permease component (possible copper exporter), putative  
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Figure 10. High throughput liquid transformation assay of candidate exporter 
mutants 
 
S. sanguinis SK36, JFP41 and exporter mutants were assayed for growth in BHI broth + 
Cm following incubation with pJFP16 ± 220 ng/ml CSP. This experiment was performed 
in triplicate and mean OD450 and SD values are indicated.  Solid bars, no CSP; striped bars, 
plus CSP. Fig. 10 is split into A and B for clarity of presentation.  
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DISCUSSION 
Genetic exchange within oral bacteria may be very important for adaptability to this 
environment which is constantly in flux. Further, there is evidence this process has worked 
to shape the genome of S. sanguinis (168).  This study attempted to further characterize 
key components of the S. sanguinis com regulon. Our examination of DNA uptake in S. 
sanguinis mutants of early regulatory genes comCDE and comX, taken together with 
previous transcriptome analysis following CSP induction support a similar role of these 
genes in DNA uptake.  Two additional early genes, SSA_0195 and SSA_1889, did not 
appear to play a role in DNA uptake, and will be examined for other functions. Analysis of 
orthologs of late com genes identified within S. sanguinis also demonstrated these genes 
function as in other competent streptococci. Taken together, the combined mutagenesis 
transformation assays and previous transcription expression data from S. sanguinis, (136) 
S. pneumoniae, (131), S. gordonii (161) and S. mutans (127) suggest a shared core regulon 
of late genes required for transformation. 
However despite these similarities to other competent streptococci, the com  
regulon of S. sanguinis demonstrates unique and uncharacterized features. These relate to 
the processing of CSP, the quorum sensing signal of this cascade. A main objective of this 
study was to determine mechanisms of ComC cleavage and the sequence of secreted CSP.  
Having determined that synthetic CSP induced competence in a comC mutant at levels 15-
fold greater than the full length uncleaved peptide, we next identified the sequence of 
secreted CSP.  Previous studies within S. sanguinis determined competence  is dependent 
on cell density and occurs in early exponential growth phase (OD660 ≈ 0.070) (136) 
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followed by a rapid drop in competence, as in S. pneumoniae (56, 152).  Our findings 
indicated that as the culture density increased, the amount of active CSP within the media 
increased as well. Although evidence exists that S. sanguinis cells are not active for DNA 
uptake at intervals beyond 40 minutes after the onset of competence, or at densities greater 
than 108 CFU/ ml (136) our findings suggest continued secretion of CSP at later cell 
densities.  This is in agreement with a recent transcriptome analysis performed within S. 
sanguinis which indicated that although the comDE operon upregulation was highest at 5 
minutes CSP post exposure; these genes did not reach basal levels at 30 minutes post 
induction (136). Later waves of competence have also been observed within S. pneumoniae 
(22). 
Our findings of the cleavage site of ComC to CSP are in agreement with those 
predicted by Havarstein (59), and indicated the ComC translation product begins as a 35 
amino acid precursor with the C-terminal 15 amino acids corresponding to the biologically 
active CSP with the sequence Asp-Leu-Arg-Gly-Val-Pro-Asn-Pro-Trp-Gly-Trp-Ile-Phe-
Gly-Arg. The 20 amino acids N-terminal leader peptide appears to be removed either 
before, during, or after secretion of CSP from the cell, although no evidence of the full 
length sequence was found during identification (Kristina Nelson, VCU Mass Spec Core, 
personal communication).  The sequence of the leader peptide does not appear to be related 
to the N-terminal sequences required for transport of proteins across the membrane via the 
Sec pathway. Further it does not appear to be closely related to those seen in the other 
streptococcal species (Fig. 2) which possess a GG motif prior to cleavage. Within these 
other species listed in Fig. 2 there are conserved hydrophobic residues at positions -4, -7, -
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12, and -15 (56).  However, the leader peptide of S. sanguinis ComC only demonstrates the 
presence of nonpolar amino acids within 2 of these domains -12 (Ala) and -15 (Phe). This 
study determined cleavage occurs after the non polar FW motif prior to the + 1 Asp 
residue, the presence of a +1 Asp this also seen in majority of species in figure 2.  The 
presence of FW as a potential cleavage signal does not appear to be a previously 
characterized motif signaling peptide cleavage. However cleavage prior to Asp residues 
can occur through activity of the Asp-N endopeptidases.  Examination of S. sanguinis 
ComC for predicted cleavage sites with ExPASY Peptide Cutter reveals a single cut at 
position 20 just prior to the +1 Asp, using Asp-N endopeptidase.  Activity of this gene was 
demonstrated in Pseudomonas fragi (68); however neither a BLASTP nor a TBLASTN 
search did not identify any related open reading frames within S. sanguinis. 
In the experiments described above, it should be noted the CSP mass and sequence 
determination were based upon separation and analysis of all secreted peptides from S. 
sanguinis. Follow-up studies sought to create a purer fraction based of the size of the 
analyzed peptide.  Because CSP has a mass of 1.77 kDa, filtered competent SK36 
supernatant was separated using 10 kDa size exclusion columns and the filtrate (<10kDa) 
was tested for transformability with JFP41 as described above. However this did not 
induce competence within JFP41. Further examination determined active CSP to be in the 
retentate (> 10kDa), and a mixture of CSP and BSA (66 kDa) separated in the same 
manner only induced competence in JFP41 when the retentate was added (data not shown). 
Such findings suggest binding between CSP and BSA. This may explain why serum or 
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serum albumin is known to be required (125) for streptococcal transformation. Future 
studies are planned to determine the nature of this binding.  
Within S. sanguinis, both previous sequencing (168) and transcriptome analysis 
(136) failed to identify the CSP transporter.  Our findings additionally suggest that CSP is 
not exported by an ABC transporter demonstrating homology to ComA. This is not 
surprising due to the unique sequence of the mature CSP peptide, and lack of well 
characterized Gly-Gly motif.  In S. pneumoniae (102, 131), S. mutans (52, 127) and S. 
gordonii (161) bacteriocin production is linked to competence induction.  In S. gordonii, 
ComAB is also involved in the processing and secretion of bacteriocin-like peptides (61).  
In S. mutans the genes originally proposed to process transport CSP were later shown to be 
responsible for bacteriocin transport. However, use of a database mining program (26) with 
S. sanguinis SK36 failed to reveal any strong bacteriocin candidates and putative matches 
were included in the high throughput screen. Taken together, our findings suggest a unique 
mechanism of peptide transport and processing in S. sanguinis that warrants further 
investigation.  
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CHAPTER 4: ASSESSMENT OF COM REGULATORY GENES IN S. 
SANGUINIS ENDOCARDITIS VIRULENCE 
 
 
RATIONALE 
Roles for the streptococcal com regulon apart from genetic competence have been 
postulated based on the finding in S. pneumoniae that all but 23 of the 124 upregulated 
genes were individually dispensable for transformation (131). Previous studies of systemic 
disease in S. pneumoniae (8, 55, 86) and caries formation by S. mutans (94) have indicated 
that com regulon genes contribute to virulence in these species by mechanisms that are 
likely unrelated to DNA uptake. Here we examine the effect of mutation in key regulatory 
genes of the S. sanguinis com regulon, and their examination in a rabbit model of IE.  
RESULTS 
Examination of com regulatory gene mutants for IE virulence in competition assays.  
Once we had confirmed that our com regulatory mutants had the expected 
phenotypes (Chapter 3), we wanted to determine if the com regulon contributes to IE 
virulence in S. sanguinis. We began by testing the comCDE and comX mutants by 
competitive index (CI) assays in our standard rabbit endocarditis model (25, 47, 122, 156, 
157). Catheterized rabbits were co-inoculated with 108 CFU of one of the mutants and 
JFP36—an Emr derivative of SK36 that we have shown to be indistinguishable in multiple 
traits, including growth rate, genetic competence, and virulence for IE (156). CI values for 
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each rabbit are presented Fig. 11A. The comCDE mutant, JFP49, exhibited a mean CI 
value of 1.44, suggesting a modest, though significant, increase in competitiveness 
compared to the control strain, JFP36 (P < 0.05). The mean CI value for the comX mutant, 
JFP45, was 1.05, which was not significantly different from 1 (P =0.71). The results 
suggested that neither comCDE nor comX was required for IE virulence in our standard 
assay.  
Previous studies of IE in the S. gordonii rat model have demonstrated increased 
sensitivity in competition assays when inoculum levels were reduced (147, 167). To 
determine whether this might increase our ability to detect subtle changes in 
competitiveness, we tested lower co-inoculum levels (105 and 106) of JFP36 and the 
comCDE mutant in three rabbits each. The CI values for two rabbits from each group are 
shown in Fig. 11B. In contrast to our previous results, these experiments revealed marked 
variability in individual CI values at both inoculum levels. Indeed, CI values could not be 
calculated for one rabbit in each group, due to a failure to recover JFP49 from a rabbit with 
the 105 inoculum and JFP36 from a rabbit with the 106 inoculum. This variability is also 
illustrated in Fig. 11C, which shows the number of JFP36 and JFP49 CFU recovered in 
each experiment. As seen in Fig. 11C, the use of lesser inocula generally resulted in lower 
and more variable recoveries of both strains, suggesting a bottleneck effect, whereby too 
few cells establish infection to ensure accurate representation of each strain (63, 122, 157). 
In contrast, use of a 108 inoculum resulted in highly reproducible recovery of both strains.  
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Figure 11.  Examination of com mutants in a competitive index model of rabbit 
endocarditis at multiple inoculum levels.  
 
Each symbol represents data from a single rabbit.  
(A) CI values from rabbits inoculated with 108 CFU. Geometric mean CI values from the 
combined results of two experiments are indicated in parentheses and by horizontal bars. 
(B) CI values from rabbits inoculated with 105 or 106 CFU.  
(C) Recovery of competing strains from infected vegetations at multiple inoculum levels. 
Each pair of connected circles indicates recovery of JFP36 (filled circles) and JFP49 (open 
circles) from the same rabbit. Data are from experiments depicted in panels A and B. 
Dashed line, limit of detection; *, mean CI value significantly different from 1 (P< 0.05). 
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Figure 11. 
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Examination of com regulon mutants for IE virulence and pathogenesis by 
individual inoculation.  
Our finding that neither com regulatory mutant showed attenuation of IE virulence 
prompted us to consider other modifications to our virulence assay. First, we considered 
the possibility that strains might be affected by co-inoculation, with one strain producing, 
for example, a trans-acting factor that had an effect on the other. This possibility could be 
eliminated by inoculating mutant and control strains into separate animals. In addition, this 
would allow for comparison of the pathology caused by each strain. We also considered 
the possibility that a longer infection period would reveal a contribution of the com regulon 
to virulence that was not apparent from the 20-h infection employed in our previous 
assays. This, too, would represent a relevant condition, since streptococcal IE typically 
progresses for days or weeks before detection and treatment (9, 108). Finally, we also 
considered the possibility that virulence differences might be obscured by variation in 
colony counts caused by chain length variation, as mutation of comX resulted in longer 
chains relative to JFP36 (Fig. 12). If this were the case, we would expect two strains with 
equal OD660 to have varying inocula with the strains with the longer chains resulting in less 
CFU. We simultaneously tested all three possibilities by sonicating strains prior to 
inoculation and after recovery from the animal to eliminate potential chain-length 
differences, inoculating mutant strains and JFP36 into separate rabbits, and extending the 
infection time to 5 days. A total of eight rabbits each were inoculated with 108 CFU of the 
comCDE or comX mutants, or JFP36. The results are presented in Table 5. The total 
number of CFU recovered from vegetations for each of the three strains did not differ 
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significantly. We next compared recovery in terms of bacterial density within vegetations. 
No significant differences were observed when the recovery levels were normalized by 
vegetation mass. We also compared bacterial levels in the blood just prior to sacrifice. 
There was also no significant difference in bacteremia levels among the three strains.  
 
Assessment of pathology among strains  
 We next examined pathology resulting from infection by comparing mortality, 
weight loss, and vegetation mass among the groups of rabbits. As shown in Fig. 13A, two 
rabbits each inoculated with comCDE and comX mutants died on day four, while all eight 
rabbits infected with JFP36 survived until day 5. Kaplan-Meier survival analysis indicated 
there was no significant difference in mortality among the groups. Since weight loss has 
previously been shown to be a reliable indicator of IE severity in a rabbit model (34), 
infected rabbits were weighed daily throughout the study. As shown in Fig. 13B, total 
weight loss after five days of infection did not differ significantly among rabbits infected 
with each strain. Likewise, no significant differences among groups were observed on days 
1 – 4 post-infection (data not shown). Figure 13C shows the masses of vegetations 
recovered at the end of the five-day infection. Our results indicated no significant 
differences in vegetation mass for rabbits infected with each of the three strains. Further, 
no consistent morphological differences were observed upon gross examination of the 
vegetations (data not shown). Taken together, our results suggest that the S. sanguinis com 
regulon is not required for IE virulence or pathology under a variety of assay conditions, 
and that deletion of the comCDE genes may, in fact, modestly increase virulence. 
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Figure 12. Examination of chain length variation among JFP36 and com mutants 
Strains indicated were harvested in PBS prior to endocarditis study. Top indicates 
strains prior to sonication and bottom following 3 min sonication at 50% power. Strains 
were adjusted to OD660 corresponding to 108 CFU/ml. Images were taken at 400X 
magnification on a phase contrast microscope. 
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Table 5. Recovery of S. sanguinis strains from experimentally infected rabbits 
 
   Vegetationa Blooda 
Strain Total CFU CFU/g CFU/ml 
JFP36 1.7 x 108 8.5 x 108 1.2 x 103 
 (1.6 x 106 - 1.8 x 1010) (1.7 x 107 - 4.6 x 109) (3.0 x 101 - 5.0 x 104) 
comCDE 9.8 x 108 4.1 x 109 2.9 x 103  
 (1.7 x 108 - 5.7 x 109) (1.5 x 109 - 1.1 x 1010)b (1.8 x 102 - 4.4 x 104)c
comX 4.4 x 108 2.6 x 109 1.0 x 103 
 (8.6 x 107 - 2.2 x 109) (9.4 x 108 - 7.2 x 109)b (1.8 x 102 - 6.1 x 103)c
a Geometric Mean (upper and lower 95% confidence interval). N = 8 rabbits, except as 
 indicated. 
b N =7  
c N =6  
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Figure 13. Assessment of IE pathology in rabbits inoculated with JFP36 or com 
mutants.  
Rabbits were inoculated with 108 CFU of JFP36, JFP49 (comCDE), or JFP45 (comX). Data 
were combined from two separate experiments, each of which included all three strains.  
(A) Survival curve. 
(B) Total weight loss 5 days post-infection. Horizontal dashed line represents no weight 
loss.  
(C) Mass of aortic valve vegetations 5 days post-infection. 
 For B and C, each symbol represents the value from a single rabbit, and horizontal lines 
indicated geometric means. No significant differences among strains were observed in any 
of the analyses. 
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Figure 13. 
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DISCUSSION 
As seen in Chapter 3, deletion of either comCDE, which activates the early com 
genes, or comX, which is required for the late response, produced the identical phenotype 
of eliminating competence in S. sanguinis. We did not want to assume that the same would 
be true with regard to com regulon functions other than genetic competence. A number of 
early com regulon genes with functions involving cell lysis, virulence and biofilm 
formation have been identified in other streptococcal species, and some have been shown 
to be expressed in a comX mutant (127, 131, 161). If one of these genes encodes a 
virulence factor, comCDE mutation would be expected to reduce virulence while a comX 
mutation would not. Conversely, instances of activation of ComX-dependent genes in the 
absence of comCDE have also been reported (44, 103, 120, 121). Thus, a ComX-
dependent virulence gene might be expressed in a comCDE mutant, but not in a comX 
mutant. Finally, different comD mutations have been shown to either increase or decrease 
S. pneumoniae colonization depending on their effect on comE expression (80). We 
therefore chose to examine virulence both in a mutant deleted for the entire comCDE 
operon and in a mutant deleted for comX.  
Using a variety of assays and measures, we determined that neither comCDE nor 
comX-dependent genes were required for IE virulence in S. sanguinis using our rabbit 
model of IE. Our study appears to be the first to examine the effect of comX mutation on 
streptococcal virulence for any disease, although ComX-dependent genes encoding 
competence protein CoiA, a choline-binding protein CbpD, and the LytA autolysin were 
identified as contributing to virulence for pneumonia in a mutant screen of S. pneumoniae 
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(55). Comparison of the virulence of a comX mutant to strains possessing mutations in 
each of these genes and in comCDE could clarify the role of the comX gene for virulence 
in S. pneumoniae.  
As far as we are aware, the effect of comCDE deletion on virulence has been 
examined previously in only one other streptococcal species, S. mutans, where it was 
shown that a comCDE mutant had reduced cariogenicity in a rat model (94). The 
mechanism was not determined, but one possibility is suggested by reports that com 
regulon induction causes cell lysis by mechanisms that include activation of bacteriocins 
and autolysins (81, 127, 159) and, further, that lysis contributes to increased biofilm 
formation (95, 126, 129, 169). The ability to form biofilms has been shown to be critical 
for cariogenicity of S. mutans, likely by contributing to adherence to the tooth surface and 
by providing a carbohydrate source for nutrition and acid production (53, 111). A 
reduction in biofilm formation in a comCDE mutant might thus explain the strain’s 
reduced cariogenicity. This study also determined that CSP enhances biofilm formation in 
S. sanguinis in a comCDE-dependent manner. Unlike the case in S. mutans, however, S. 
sanguinis mutants completely deficient for in vitro biofilm formation (due to mutations in 
non-com regulon genes) are unaffected in IE virulence, using our rabbit IE model (47). 
Therefore, biofilm reduction resulting from comCDE mutation would not be expected to 
reduce IE virulence in S. sanguinis.  
Given the distinct nature of caries formation, S. pneumoniae studies of com mutants 
may provide a more relevant comparison. In S. pneumoniae, studies employing comD 
mutants have reported attenuated virulence in murine models of respiratory tract infection 
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(8, 55, 86), systemic infection (8), and bacteremia (86). As with S. mutans, the mechanisms 
by which comD contributes to virulence in S. pneumoniae are not known. It has been 
shown that com regulon induction in S. pneumoniae induces cell lysis by mechanisms 
related to those in S. mutans (49, 60). It has also been shown that comCDE-dependent cell 
lysis in S. pneumoniae results in release of the cytoplasmic virulence factor pneumolysin 
(49). This is likely mediated at least in part by the major autolysin, LytA, encoded by a 
com regulon gene (12, 131). This could explain not only the reduced virulence of these 
mutants in assays examining pathology or death, but also the increased fitness for 
asymptomatic upper respiratory tract carriage of a comE mutant (80), since in this 
environment, it may be beneficial to avoid damaging host tissue. It is not clear whether 
com-dependent lysis occurs in S. sanguinis or not, but it was interesting to note the 1.4-fold 
advantage of the S. sanguinis comCDE mutant in the competition assay. This was 
accompanied by a slight increase in growth of this mutant in BHI broth culture compared 
to SK36 or JFP36 (data not shown). It is possible that this was the result of comCDE-
dependent cell lysis in the wild-type strains. This could suggest that IE virulence in S. 
sanguinis is more akin to S. pneumoniae colonization than to pneumonia or other invasive 
diseases. This would be consistent with our findings that S. sanguinis endocarditis appears 
to mainly involve continued growth of the bacteria resulting in progressive enlargement of 
the infected vegetation, as opposed to the myocardial abscess formation that often occurs 
with other IE pathogens such as Staphylococcus aureus (9). This would also be consistent 
with a recent finding that an endocarditis isolate of S. sanguinis was defective for 
competence (170). In summary, then, com regulon activities apparently required for 
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virulence in S. mutans and S. pneumoniae may also occur in S. sanguinis but appear to play 
no role in IE virulence. It would be of interest to examine a comCDE mutant of 
Streptococcus mitis for IE virulence since this species is similar to S. sanguinis with regard 
to frequent isolation from IE cases, but is phylogenetically closer to S. pneumoniae and 
possesses a pneumolysin ortholog (31).  
Our study was also useful for defining the limits of the rabbit IE model. We found 
that inoculum levels of 105 to 106 CFU were insufficient to ensure infection. Although this 
would not preclude their use in ID50 studies, larger inocula are clearly required to obtain 
meaningful results from competition assays. We also explored the use of infection periods 
longer than the 2 and 20-hr periods we have employed previously in this model (25, 47, 
122, 157). Four deaths occurred prior to the end of study, all on day four. This is in 
contrast to the 20-hr infections performed here, in which no animals died prematurely, as 
well as our previous experiments with this model, in which premature deaths have been 
exceedingly rare (unpublished data). Upon necropsy, we observed that vegetations in all 
animals were far larger than we typically observe, averaging 182 mg in this study 
compared to 59 mg for a previous study (157) employing a 20-hr infection (P = 0.0034; 
unpaired t test). This may have caused congestive heart failure by occluding blood flow, or 
have resulted in embolic stroke. We therefore suggest that any future studies with this 
model be limited to three days’ duration, at least when applied to S. sanguinis.  
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CHAPTER 5:  ANALYSIS OF COM GENES IN S. SANGUINIS 
BIOFILM DEVELOPMENT AND ENHANCEMENT 
 
 
RATIONALE: 
Previous studies in S. mutans and S. pneumoniae have indicated that the com 
regulon is involved in biofilm formation (95, 119). The link between competence genes 
and biofilm development in other streptococci, the beneficial role of S. sanguinis in the 
oral environment, and evidence of DNA exchange within this niche prompted our 
investigation of S. sanguinis com regulon genes in relation to biofilm formation.  Here we 
examine functions of the S. sanguinis com regulon beyond DNA uptake, to investigate its 
importance in biofilms.  
 
RESULTS: 
Quantitative examination of the contribution of the com regulon to biofilm formation  
To determine whether the S. sanguinis com regulon plays a role in biofilm 
development, we first examined SK36, the isogenic comCDE and comX mutants , and an 
in-frame comC deletion strain created previously (136) for biofilm formation using a 
standard CV assay (118). The optical density of the solubilized stain, commonly used as a 
measure of biofilm abundance (47, 118), is indicated in Fig. 14A.  Similar staining was 
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observed in SK36 and the comC and comCDE mutants.  However, the comX mutant 
biofilm retained 2.3-fold more stain than SK36 (P< 0.001).  
Previous studies in other streptococcal species have demonstrated involvement of 
the com regulon in biofilm formation by treatment of cells with exogenous CSP (119, 129, 
169). We therefore examined the effect of added CSP on biofilm development in S. 
sanguinis. Biofilms were allowed to form in the presence of 220 ng/ml CSP, a level 
previously shown to be optimal for competence induction in the comC mutant, JFP41 
(136). As indicated in Fig. 14B, addition of CSP significantly enhanced biofilm staining in 
SK36 and the comC mutant (P< 0.001), both of which are capable of com regulon 
activation by CSP.  No enhancement was observed in the comCDE mutant, suggesting that 
CSP exerted its effect through the com regulon.  
We observed no enhancement in biofilm formation in the comX mutant upon 
addition of CSP. One possible explanation for this finding was that autologous CSP 
production is sufficient to produce the biofilm-enhancing effect in this strain. 
Alternatively, the mutation could exert its effect independently of CSP. To distinguish 
between these possibilities, we constructed a comXcomC mutant, JFP60, and assessed it for 
biofilm formation using the same assay.  Fig. 14B indicates that the level of biofilm 
formation in a comXcomC mutant was not significantly different from SK36 in the absence 
of added CSP. However, addition of CSP to a comXcomC mutant increased biofilm levels 
significantly (P< 0.001), to that of the comX mutant. Taken together, our results  
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Figure 14.  Examination of biofilm formation in SK36 and selected com mutants by 
crystal violet staining 
 
The strains indicated were assessed for biofilm formation in the  
(A) Absence and  
(B)  Presence of exogenous CSP, with CV staining reported as OD600. Means and SD 
values derived from three independent assays are shown. White bars, no CSP; black bars, 
plus CSP. A. *, significantly different from SK36 (P<0.001). 
B. *, significantly different from the same strain to which no CSP was added (P<0.001). 
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demonstrate that CSP enhances biofilm formation, and that this enhancement requires 
ComDE but not ComX.  
Examination of the contribution of the com regulon to biofilm structure 
We next examined the morphology of the biofilms produced by these strains.  
CLSM was used to visualize 20-h biofilms reacted with a live-dead stain on polystyrene 
plates. As seen in the representative CLSM micrographs in Fig. 15, both SK36 and the 
comC mutant produced relatively uniform biofilms with distinct chains apparent. The 
comC mutant biofilms were, however, somewhat less dense.  Addition of CSP to SK36 and 
comC appeared to slightly increase biofilm dispersion and height.  In contrast, the comX 
mutant biofilm exhibited striking differences, producing denser, punctate biofilms with 
notable red and yellow fluorescence, and with clumps rather than clearly discernable 
chains. The comCDE and comXcomC mutants were also examined by CLSM, and also 
exhibited biofilms similar to those produced by the comC mutant.  CSP addition had no 
effect on biofilm appearance in the comCDE or comX mutants, in agreement with 
expectation established from biofilm assay. When CSP was added to the comXcomC 
mutant, its appearance was altered dramatically and became similar to that of the comX 
mutant.  
 Biofilm surface topology was also examined by scanning electron microscopy 
(SEM), as shown in Fig. 16.  SK36, comCDE, comC, and comXcomC mutant biofilms 
were again similar in appearance, with distinct chains prominent within a tight meshwork, 
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interspersed with occasional and inconsistent cracks or gaps. In contrast, comX mutant 
biofilms possessed altered structures with large gaps, often producing mushroom-like 
structures. CSP addition had little observable effect on biofilm appearance in SK36, and 
the comC, comCDE or comX mutants. However, as in CLSM, addition of CSP, altered the 
comXcomC mutant’s appear to mirror that of the comX mutant.  The combined results 
suggest that induction of the com regulon by CSP significantly increases biofilm biomass, 
and that induction of early com genes in a comX mutant produces a biofilm with a 
dramatically altered architecture.   
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Figure 15. Microscopic examination of biofilms using Confocal Laser Scanning 
Microscopy 
  
Strains were examined in the (A) absence or (B) presence of exogenous CSP, as indicated.  
Biofilms stained with live/dead stain visualized by CLSM at 400 x. In each image, top 
panels represent the xy plane; bottom panels represent the xz plane. The white line 
indicates the z-projection for the corresponding image and was selected at the midpoint of 
the biofilm height.  
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Figure 16. Scanning Electron Microscopy examination of biofilms 
 
SEM of biofilms formed on glass coverslip in the (A) absence or (B) presence of 
exogenous CSP as indicated, displayed at 2,000x. 
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Identification of a gene responsible for com-dependent biofilm enhancement  
 We next sought to identify the gene(s) responsible for the CSP-dependent 
enhancement of biofilm formation. Given our finding that this increase required functional 
comDE genes and occurred in the absence of a functional comX gene, we hypothesized that 
upregulation of a gene belonging to the early com response was responsible for CSP-
dependent biofilm enhancement. This laboratory’s recent transcriptomic analysis of a 
comC mutant using microarray (136) and qRT-PCR suggested that the S. sanguinis early 
response is comprised of only six genes: comCDE, comX, SSA_1889, and SSA_0195. 
Having tested the role of the first four genes in biofilm formation, we turned our attention 
to the others. SSA_1889 is annotated as a conserved uncharacterized protein. Apart from 
alleles in other S. sanguinis genome-sequenced strains, its closest match in GenBank is a 
hypothetical protein from S. anginosus (ZP_08014095.1). SSA_0195 is annotated as a 
hypothetical protein whose closest matches are also alleles from other S. sanguinis strains, 
followed by a hypothetical protein from Streptococcus cristatus (ZP_08059937.1). 
SSA_0195 also possesses weak similarity to the S. pneumoniae immunity protein ComM 
(60).  
 Because we have previously determined that these genes are not required for DNA 
uptake (136), mutants of SSA_1889 (JFP65) and SSA_0195 (Ssx_0195) (23)were next 
examined for biofilm formation.  The results of a CV biofilm assay are shown in Fig. 17. 
Similar levels of biofilm formation were observed in SK36 and the SSA_1889 and 
SSA_0195 mutants in the absence of added CSP. As in SK36, biofilm formation was 
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significantly enhanced by CSP in the SSA_1889 mutant (P<0.001). In contrast, CSP failed 
to enhance biofilm staining in the SSA_0195 mutant. To confirm no morphological 
differences in SSA_0195 biofilms, we examined biofilms produced in the absence and 
presence of CSP by SEM. As seen in Fig. 17 B, SSA_0195 mutant biofilms did not vary 
from those produced by SK36 (cf. Fig. 16) either in the presence or absence of CSP.    
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Figure 17.  Examination of biofilm formation in SK36 and selected mutants by CV 
staining 
 
A.  The strains indicated were assayed for biofilm formation ± exogenous CSP as in Fig. 
14.  Mean and SD values derived from three independent assays are shown.  White bars, 
no CSP; black bars, plus CSP; *, significantly different from the same strain to which no 
CSP was added (P<0.001). 
 
B. SEM of SSA_0195 mutant biofilms formed on glass coverslip in the absence or 
presence of exogenous CSP as indicated, displayed at 2,000x. 
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Examination of SSA_0195 in biofilm enhancement 
 Our findings suggested that SSA_0195 was required for CSP-dependent biofilm 
enhancement. To determine whether this gene was also sufficient for this phenotype, we 
sought to examine the effect of overexpressing SSA_0195. We employed a plasmid that 
has been used for IPTG-inducible expression in Bacillus subtilis, pDR110 (a kind gift from 
David Rudner, Harvard Medical School). To confirm that this expression system would 
function in S. sanguinis, we cloned the gfpmut3* gene from pCM18 (54) encoding green 
fluorescent protein (GFP) into the pDR110 expression site.  We then transferred the 
gfpmut3* gene and flanking pDR110 regulatory sequences into the E. coli-streptococcal 
shuttle vector, pVA838 (100), transformed SK36 with this plasmid, and confirmed IPTG-
inducible expression of GFP by Western Blot analysis (data not shown).  We then similarly 
cloned SSA_0195 into pDR110 to produce plasmid pJFP93 (Fig. 18A) and then into 
pVA838 to produce plasmid pJFP94 (Fig. 18B), as described in Materials and Methods.  
We next transformed the SSA_0195 mutant with pJFP94, and the resulting strain was 
assessed for biofilm formation with increasing concentrations of IPTG.  As shown in Fig. 
19A, an IPTG dose-dependent increase of biofilm staining was observed, with a maximum 
response occurring at 62.5 μM IPTG. This suggested that increased expression of the 
SSA_0195 gene in response to CSP might be sufficient for the CSP-dependent biofilm 
enhancement observed in our earlier experiments. However, since the SSA_0195 mutant 
possesses an intact comC gene capable of producing CSP, and the ComDE receptor and 
activator, we could not be certain that induction of other early com genes was not also 
required for increased biofilm formation. We therefore introduced pJFP94 into the comC 
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mutant, JFP41.  As shown in Fig. 19A, JFP41 (pJFP94) also demonstrated increased levels 
of biofilm formation in response to IPTG. This suggested that upregulation of early com 
regulon genes by intrinsic CSP production is not required in addition to SSA_0195 
upregulation for augmentation of biofilm formation. Indeed, CV staining was significantly 
(P<0.05) greater in the comC (pJFP94) mutant relative to Ssx_0195 (pJFP94) at IPTG 
concentrations up to 32 µM, after which similar levels of biofilm formation were observed 
in both strains.  
As shown in Fig. 19B, biofilms were also examined by CLSM in the presence or 
absence of IPTG at 125 µM—a concentration beyond which increased biofilm staining did 
not occur in the CV assay. Mutation of SSA_0195 resulted in reduced biofilm density 
compared to SK36 (cf. Fig. 15A).  Overexpression of SSA_0195 in Ssx_0195 (pJFP94) 
resulted in increased fluorescence relative to that of the Ssx_0195 mutant. JFP41 (pJFP94) 
biofilms formed in the presence of IPTG also exhibited an increase in biofilm fluorescence 
relative to JFP41 (cf. Fig. 15A), and the addition of CSP had little effect. Taken together, 
our results indicate that upregulation of SSA_0195 is sufficient to cause CSP-dependent 
biofilm enhancement. 
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Figure 18.  Plasmid Maps of pJFP93 and pJFP94 
A) SSA_0195 and native RBS were placed under the control of IPTG inducible promoter 
Pspank in Bacillus subtilis plasmid pDR110 via unique 5’ SalI and 3’ SphI sites to create 
pJFP93. 
 
B) An EcoRI/BamHI fragment containing the Pspank promoter, SSA_0195, and lacI from 
pJFP93 was ligated into the EcoRI/BamHI sites of the E. coli-streptococcal shuttle vector 
pVA838 to create pJFP94.   
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Figure 18. 
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Figure 19.  Analysis of the effect of SSA_0195 expression on biofilm formation 
 
(A) The strains indicated were assayed for biofilm formation as in Fig. 14, except that 
biofilm formation occurred in the presence of IPTG at the concentrations shown. The assay 
was performed three times in quadruplicate, and a representative assay is shown.  *, value 
significantly different from Ssx_0195 (pJFP94) at the same IPTG concentration (P<0.05).  
(B) CLSM of SK36 derivative strains ± 125 μM IPTG and CSP at 400x.  
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In S. pneumoniae, ComX functions not only to upregulate late genes, but also to 
shut down early com gene transcription, through activity of one of more of its late gene 
products (88). If this is also true in S. sanguinis, a comX mutant would be expected to 
exhibit upregulation and perhaps continuous expression of early genes. In an S. sanguinis 
comX mutant, we observed an altered, dense, and punctate biofilm. This was also seen in 
biofilms of a comXcomC mutant (Figs. 15 & 16) with added CSP.  The simplest 
explanation for this phenotype was that overexpression of the early gene SSA_0195 in the 
absence of ComX was responsible. We did not observe an altered phenotype when 
SSA_0195 was overexpressed in strain JFP96.  However, because this strain contains 
comX, we couldn’t be sure that comX was not being expressed at low levels, thereby 
altering the biofilm phenotype.  We therefore tested this possibility by overexpressing 
SSA_0195 in a comXcomC mutant (JFP114). As seen in Fig 20A, overexpression of 
SSA_0195 by IPTG addition to JFP114 increased biofilm straining relative to plasmid 
control, but did not produce a biofilm with a punctate phenotype unless CSP was added. 
Taken together these findings suggest that overexpression of an early gene other than 
SSA_0195, in the absence of comX, was necessary for the comX mutant phenotype.    
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Figure 20.  Analysis of the effect of SSA_0195 expression on biofilm formation in a 
comXcomC mutant 
 
CLSM of SK36 derivative strains ± 125 μM IPTG and ± CSP at 400x. 
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Examination of the effects of CSP on cell growth or survival 
We next sought to examine the mechanism by which SSA_0195 enhances biofilm 
formation. CSP-dependent cell lysis accompanied by DNA release has been observed 
previously in other streptococcal species (126, 141), and has been linked to enhancement 
of biofilm formation (95, 96, 129). To determine whether this was also occurring in S. 
sanguinis, we first examined the effect of exogenous CSP on growth kinetics. CSP 
treatment of the comC mutant caused a marked delay in growth as measured by optical 
density (Fig. 21A), which is consistent with CSP-mediated cell killing or growth 
inhibition. However, CSP had little effect on the growth of SK36. One explanation we 
considered for this based on data described below is that addition of CSP at high 
concentrations to CSP-naïve cells might produce a greater effect than when CSP was 
added to cells producing autogenous CSP. This could occur if exposure to low levels of 
CSP provided partial tolerance to higher levels. The comCDE mutant grew as well as 
SK36 in the presence or absence of CSP, suggesting the CSP growth attenuation observed 
in the comC mutant is mediated through the com regulon. We predicted that if the CSP 
effect on growth, like its effect on biofilm formation, was dependent on SSA_0195 
expression, then the SSA_0195 mutant would grow equally well in the presence and 
absence of exogenous CSP. There was indeed only a minor effect of CSP on growth of the 
SSA_0195 mutant; however, growth was significantly impaired in this strain in the 
absence of CSP relative to SK36 at all time points from early exponential growth until the 
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beginning of stationary phase. Thus, mutation of SSA_0195 appeared to modestly reduce 
viability or growth regardless of added CSP. 
To clarify the role of SSA_0195 in CSP-mediated growth attenuation, we next 
examined strains overexpressing SSA_0195, along with their plasmid controls, using the 
same assay. We hypothesized that if SSA_0195 were responsible for the growth effect, an 
overexpressing strain would exhibit a reduced growth rate relative to a plasmid control. As 
seen in Fig 21B, overexpression of SSA_0195 in Ssx_0195 (pJFP94) did not affect its rate 
of growth relative to its plasmid control strain, Ssx_0195 (pVA838). Additionally, the 
growth rates of both strains were lowered by CSP. This suggested that the CSP effect on 
growth was independent of SSA_0195 expression. We also examined JFP41 (pJFP94).  As 
seen in Fig. 21C, overexpression of SSA_0195 in JFP41 (pJFP94) significantly enhanced 
the growth rate relative to the plasmid control, JFP41 (pVA838), which would not be 
expected if CSP-dependent growth inhibition were mediated by SSA_0195 
overexpression.  
As another test of the effect of CSP on growth or viability, we performed standard 
transformation assays in which cells were exposed to DNA in the presence and absence of 
exogenous CSP for 90 minutes and then plated for viable counts in the absence of 
antibiotics. As seen in Fig. 21D, addition of CSP significantly reduced the number of CFU 
recovered for the comC mutant compared to no CSP addition (P<0.02). SK36 and 
comCDE mutant CFU were not affected by CSP. Viable counts of the SSA_0195 mutant 
appeared slightly reduced, but this difference was not significant (P=0.15). As with the  
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Figure 21. Examination of the effect of CSP on growth and viable counts of S. 
sanguinis strains 
(A – C)  Optical densities of strains grown in THHS in the presence (+) or absence (-) of 
added CSP. 
A) SK36 and early com mutant strains 
(B and C) Strains containing SSA_0195 expression plasmid pJFP94 or the control plasmid 
pVA838, and grown in the presence of 125 μM IPTG. For A – C, error bars were removed 
for clarity. Assays were performed in triplicate and the mean values of a representative 
assay are shown.  Closed symbols and solid lines, no CSP; open symbols and dashed lines, 
plus CSP.   
(D) Percent recovery of selected strains following incubation with CSP compared to no 
CSP treatment. * Significantly different from the same strain to which no CSP was added 
(P<0.05). 
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growth studies, these results were consistent with a CSP-dependent, com regulon-
dependent reduction in viability or growth in CSP-naïve cells. 
 
Examination of DNA in S. sanguinis biofilms 
 Although we could not demonstrate cell death as a result of increased SSA_0195 
expression, we nevertheless looked for evidence that CSP-dependent biofilm enhancement 
resulted from incorporation of extracellular DNA into the biofilm. DNase I was added to 
the biofilm medium ± CSP in varying concentrations at the onset of biofilm formation in 
SK36, a comC mutant, and a comX mutant. In SK36, CV staining was significantly 
reduced in both the presence and absence of CSP by addition of DNase I at concentrations 
≥100 units/ml (Fig. 22A). A similar result was observed for the comC mutant (Fig. 22B). 
These findings suggest that extracellular DNA is a component of S. sanguinis biofilms, and 
that activation of the com regulon is not required for its incorporation. Interestingly, comX 
mutant biofilms were more sensitive to DNase I than biofilms from the other strains, 
demonstrating significantly reduced staining with only 50 units/ml DNase I (Fig. 22C), in 
the presence or absence of exogenous CSP. 
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Figure 22.  Effect of DNase I on biofilm formation in the absence and presence of 
exogenous CSP  
 
Biofilm formation was examined by CV staining as in Fig. 14, except that biofilm 
formation occurred in the presence of DNase I at the concentrations indicated. The assay 
was performed three times in quadruplicate and the mean values and SD of a representative 
assay are shown. (A) SK36 (B) JFP41 (C) JFP45. *, significantly different from cells 
grown in the same condition (either with or without CSP) in the absence of DNase I 
(P<0.05); the symbol applies to both samples in all cases.  
D) Polystyrene plate showing biofilm strains treated with DNaseI, stained with CV  
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Figure 22D. 
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DISCUSSION 
 
Our examination of the contribution of the com regulon to biofilm formation was 
motivated by a number of factors. S. sanguinis principally colonizes teeth (1), and its 
habitat is therefore primarily the dental plaque biofilm. DNA sequencing reveals that the S. 
sanguinis genome has been shaped to a large degree by transformation (168), suggesting 
its com regulon is active in biofilms. This would also be consistent with findings from S. 
pneumoniae (119) where transcriptomic analyses revealed increased levels of com regulon 
genes in biofilms relative to those in planktonic growth, and in S. mutans (93), where 
biofilm-grown cells demonstrated increased levels of transformation compared to 
planktonic cells. Moreover, these studies also demonstrated involvement of the com 
regulon in biofilm formation.  
We detected no differences in biofilm mass or morphology in comC or comCDE 
mutants in the absence of added CSP.  These findings differ from those seen in S. gordonii, 
where a comD mutant failed to form a biofilm (96), and in one study of S. mutans, where 
comD or comE mutants were deficient in biofilm formation (95). Our findings of biofilm 
enhancement by CSP are, however, reminiscent of studies with S. pneumoniae, where CSP 
dramatically enhanced biofilm formation in wild-type strains (119). Also, although 
autogenous CSP production is sufficient to enhance biofilm formation in S. mutans, 
addition of exogenous CSP increases biofilm formation further (129, 169). It is possible 
that apparent differences in CSP requirements are largely the result of particular assay 
conditions. In a recent study of S. sanguinis SK36, exogenous CSP had no effect on 
biofilm formation (170). However, the culture conditions used in that study (aerobic BHI 
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incubation) have been shown previously (47) to produce less biofilm than the conditions 
employed here. It’s possible that further testing would reveal assay conditions in which 
biofilm formation is both abundant and responsive to autogenous CSP. Considering that S. 
sanguinis exists in an environment characterized by frequent changes in pH, oxygen 
tension, nutrient availability, cell density, and co-resident species, there are numerous 
biologically relevant conditions that could be tested. 
Previous studies of CSP-dependent biofilm formation in S. mutans (129, 169) and 
S. pneumoniae (119) and of CSP-dependent allolysis (49) and cell clumping (60) in S. 
pneumoniae suggest these processes are related. Published findings are largely consistent 
with a model in which CSP upregulates expression of bacteriocins and/or cellular 
autolysins, which results in increased cell lysis and increased release of extracellular DNA, 
which then increases biofilm formation (or clumping) in a manner that requires binding of 
the DNA to the cell surface. The CSP-dependent reduction in cell culture densities and 
viable counts observed in our study was consistent with this model. Other results, however, 
were not. First, our data suggested CSP-dependent effects on cell numbers were greatest 
when CSP was added to strains capable of CSP sensing but not production, whereas the 
CSP effect on biofilm augmentation was unaffected by the strain’s capacity for autogenous 
CSP production. Thus, the effects of CSP on cell numbers and biofilm augmentation were 
genetically separable. Second, the effect of CSP on biofilm enhancement appears to result 
directly from induction of SSA_0195 expression; thus SSA_0195 overproduction from an 
IPTG-induced promoter would be expected to have the same effect on cell numbers as 
addition of CSP. This outcome was not observed. Third, in strains capable of CSP sensing, 
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this model predicts increased cell lysis and extracellular DNA in the biofilms of cells 
treated with CSP compared to untreated cells. With the staining method employed in our 
CLSM analysis, intact cells are expected to appear green while cells with impaired 
membranes should appear red or yellow, as should extracellular DNA (50). Yet, there was 
very little increased red or yellow staining in biofilms formed from cells treated with CSP 
as compared to untreated (Fig. 15 for SK36 and comC mutant). Likewise, there was little 
effect on red or yellow staining in biofilms of cells induced to overexpress SSA_0195 as 
compared to uninduced. Fourth, DNase I treatment produced similar effects on biofilms, 
regardless of whether CSP was present, suggesting that DNA plays an important structural 
role in biofilms of cells in the absence of CSP. Finally, in the simplest form of this model, 
the SSA_0195 gene would encode a bacteriocin or an autolysin. Yet, SSA_0195 has no 
detectable sequence similarity to known members of either class, and is instead similar to 
the ComM immunity protein from S. pneumoniae that functions to protect cells from the 
CSP-dependent lytic activity of the putative murine hydrolase CbpD and autolysins LytA 
and LytC (38, 60).  
Whether SSA_0195 functions as an immunity protein in S. sanguinis or how such 
an activity would lead to biofilm enhancement is not clear. Mutation of SSA_0195 resulted 
in a significant decrease in culture density at multiple time points in our growth study, 
suggesting the protein provides a modest growth or survival benefit to the cell. While this 
is consistent with an immunity function, many alternate explanations are possible, and the 
effect of SSA_0195 appears unrelated to CSP exposure. Bioinformatic analysis may 
provide important clues. ComM and SSA_0195 share only 23% amino acid identity and a 
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BlastP alignment e value > 10-5. (This explains why the ComM protein, SP_1945, was not 
categorized as an SSA_0195 ortholog in a previous study performed by our lab (136)). 
However, both proteins are reciprocal best matches by BlastP analysis and are both 
encoded by genes belonging to the early com response (60, 77, 131, 136). Interestingly, 
topological analysis using either TMHMM (82) or TMMOD (71) suggests that both 
proteins possess five transmembrane domains in virtually identical locations, but that 
ComM possesses a sixth transmembrane domain that results in the C terminus being 
internal to the cell, whereas the analogous region in SSA_0195 is predicted to be external 
(data not shown). Since the mechanism by which ComM confers immunity to its own 
lysins has not been determined and functional domains have not been identified (60), the 
significance of this topological difference is unknown.  
Finally, our results suggest that ComX plays a role in biofilm formation distinct 
from that of SSA_0195. comX mutant biofilms possess altered architecture, increased 
staining with CV, increased staining with propidium iodide indicative of increased cell 
death or release of DNA, and increased sensitivity to DNase I. This suggests that CSP-
stimulated biofilm production requires one or more ComX-dependent genes for normal 
architecture. This laboratory has previously identified 118 late genes in S. sanguinis (136), 
any of which may be responsible. In S. mutans, the ComX-dependent gene comGB 
required for DNA uptake and transformation was also shown to be involved in biofilm 
formation (129). Disruption of comGB reduced both CSP-dependent biofilm enhancement 
and binding of extracellular DNA to cells. Together with the finding that DNase I 
treatment reduced biofilm formation in wild-type cells, but not in the comGB mutant, these 
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results suggested that ComGB enhances biofilm formation by binding to extracellular 
DNA. It is possible that in S. sanguinis the ComGB ortholog (SSA_0185) or other ComX-
dependent proteins required for DNA uptake also affect biofilm architecture. However, the 
effect of ComX on biofilm formation in the two species is distinct. In S. mutans, a comX 
mutant produces a biofilm with decreased staining and appearance indistinguishable from 
that of a comD, or comE mutant (95). This also suggests that the CSP-dependent biofilm 
enhancement observed in S. mutans can be explained by its effect on comX expression. 
This is clearly not the case in S. sanguinis.  
Another notable finding was that it was not necessary to add CSP to observe a 
change in biofilm architecture in a comX mutant. Together with the finding that exogenous 
CSP is required to reproduce the comX phenotype in the comXcomC mutant, this suggests 
that the comX mutant may produce increased CSP compared to SK36.  We attempted to 
compare CSP levels in culture supernatants of these two strains grown for various 
durations under biofilm conditions by assaying for their capacity to induce competence 
when added to a comC mutant. Unfortunately, these experiments were unsuccessful. In 
wild-type S. pneumoniae, early genes are transcribed maximally 7.5 to 10 minutes after 
CSP addition and then return to baseline levels for 40 to 60 min before undergoing another 
cycle of activation (88, 131). The decline in transcription is largely alleviated in a comX 
mutant, suggesting it is mediated by a ComX-dependent gene (131). If this also occurs in 
biofilm-grown S. sanguinis, then the comX mutant may experience higher or more 
sustained SSA_0195 expression in the absence of exogenous CSP leading to an increase in 
biofilm.  
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Also within the comX mutant, it is not merely the absence of comX, but the absence 
of comX coupled with early gene expression, that results in an altered biofilm phenotype. 
We propose that, as in S. pneumoniae, under WT conditions, a comX dependent gene 
product serves to dampen the expression of early genes.  We further propose that in this 
regulator’s absence, the expression of the early genes remains high, leading to increased 
biofilm levels, cell death and an aberrant structure. Although overexpression of SSA_0195 
in a comX+ strain resulted in an increase in the total amount of biofilm present, it did not 
result in a biofilm with aberrant structure in a comXcomC background. . However, when 
CSP was added to the overexpressing strain in a comXcomC background, thereby turning 
on the expression of other early genes, the altered biofilm reappeared.  This suggests that 
upregulation of a different early gene is responsible for the altered biofilm phenotype of a 
comX mutant. This possibility, as well as the mechanism by which SSA_0195 enhances 
biofilm formation, are currently under investigation.    
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CHAPTER 6:  SUMMARY AND PERSPECTIVES  
 
 
 This study sought to further characterize the S. sanguinis com regulon and 
determine any involvement of this system in endocarditis virulence and biofilm formation.  
As described in chapter 1, S. sanguinis is able to colonize two very different niches—the 
oral cavity and cardiac valves. S. sanguinis is naturally competent, and its ability to acquire 
new DNA may add to competitiveness in both environments.  There is already evidence 
this process appears to have played an important role in shaping the genome of S. 
sanguinis (168).   
In chapter 3, we first demonstrated that several early and late com regulatory genes 
required for DNA uptake in the model organism S. pneumoniae were also required in S. 
sanguinis. Additionally, we sought to further characterize a unique aspect of the S. 
sanguinis com regulon by determining the sequence of processed and secreted CSP and 
identify the transport system involved in its processing and export.  The cleavage site for 
ComC was identified and the sequence of the leader peptide did not appear to possess a 
sequence similar to any characterized peptide processing motif. This suggests a novel 
signal sequence in peptide transport. Further it should be noted that determination of the 
exact mass and sequence, through Sequest analysis, of CSP reinforced the authenticity of 
studies performed in chapters 3 and 5 with synthetic CSP. This also includes a recent 
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microarray study performed within this lab (136). Additionally, despite a thorough screen 
of candidate transporter systems, the protein responsible for ComC processing was not 
identified.   Future studies are planned to examine this question. These studies will 
examine ComC processing within a heterologous host, S. gordonii.  Here comC will be 
placed under control of the Pspank promoter on shuttle plasmid pVA838. First, we will 
assure it is not being secreted by a non-dedicated transporter.  Assuming this is not the 
case, we will next create plasmid DNA libraries with fused ~ 3 kb fragments of S. 
sanguinis DNA cloned downstream of comC.  Strains transformed with these plasmids will 
then be grown in the presence of IPTG and filtered supernatant will be assessed for gain of 
function in JFP41, the S. sanguinis comC mutant.  
Once the comCDE and comX regulatory genes were shown to function as expected, 
we next assessed potential involvement of these genes in endocarditis virulence.  The data 
we have presented in chapter 4 is the first to our knowledge to examine possible roles of 
the com regulon in IE virulence for any bacterium. Using a variety of assays and measures 
within our rabbit endocarditis model, we determined that neither ComE nor ComX-
dependent genes contribute to endocarditis infection, bacteremia or pathology.  
Collectively, there are approximately 124 genes under the control of these two regulators. 
Given the genome of S. sanguinis contains about 2274 genes; this study has substantially 
contributed to screening potential genes which may contribute to IE virulence.   
Chapter 5 examined the role of the com regulon within S. sanguinis biofilm 
formation and indicated this system plays an important role in biofilm development.  Using 
both quantitative and qualitative assessment, we have determined biofilm development 
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requires the coordination of early genes for enhancement and late genes for maintaining 
normal structure. CSP-enhancement of biofilms within S. sanguinis was demonstrated to 
be com regulon dependent, occurring through the activity of early gene SSA_0195. 
Overexpression of this gene alone was sufficient to increase biofilm abundance.  Further, 
evidence supported a role of one or more ComX-dependent genes in biofilm structure. 
Despite the finding of biofilm enhancement through activity of SSA_0195, its mode of 
action with regard to biofilm enhancement and planktonic growth remain undetermined.  
Growth studies indicated this gene may offer protection to the cell. Further, this study 
demonstrated, as in many streptococcal biofilms, DNA appears to be an important 
structural component. Its entry into the extracellular matrix may be com-independent.   
Our findings have led us to propose a hypothetical model to explain S. sanguinis 
biofilm formation under three conditions. Each illustration depicts predicted levels of 
SSA_0195 and SSA_1889 expression, as well as biofilm amount. The first illustration 
(Fig. 23A) depicts formation of a basal biofilm in untreated, wild-type cells.  Here CSP is 
being produced in small amounts resulting in low expression levels of early genes.  As a 
result, levels of SSA_0195 are basal or are increased only transiently and a minimal, com-
independent biofilm is produced. A ComX-dependent protein prevents sustained, early 
gene transcription.  This model could explain why similar staining patterns and 
morphology were observed in an SK36, comC, comCDE, and comXcomC biofilms. 
In the next illustration, Fig. 23B, there is an increase in the amount of SSA_0195 
expression, either through addition of CSP to the medium or through IPTG induction of the 
plasmid-borne gene.  In the first scenario, increased transcription of other early genes also 
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occurs, including SSA_1889; however through activity of a ComX dependent protein, 
some dampening occurs, resulting in expression levels that are higher than in cells 
untreated with CSP, but lower than in comX mutant cells. The increased level of 
SSA_0195 results in an increase in biofilm levels. When SSA_0195 is overexpressed from 
the Pspank promoter, biofilm levels likewise increase. 
The last illustration, Fig 23C, depicts a comX mutant biofilm.  Here we propose 
loss of the ComX-dependent regulator eliminates the feedback loop, leading to increased 
and continuous early gene expression.  In this scenario, we propose that increased 
expression of SSA_0195 is increasing biofilms amounts, but that increased expression of 
another gene is altering the phenotype of the biofilm and increasing cell death.  One 
possible candidate is SSA_1889. Alternatively, there may be another early gene that was 
not detected in the microarray for any of a variety of reasons, including low expression at 
time zero, as in SSA_0195.    
This model could be tested by examining biofilms produced by a comX SSA_1889 
double mutant to determine if this aberrant phenotype is still present. Additionally we 
could examine a strain overexpressing SSA_1889 in a comXcomC background to 
determine if this phenotype is present. Lastly, we could use RT-PCR to analyze com genes 
expression during biofilm development in WT and mutant strains. 
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Figure 23. Model of com regulon activity during biofilm formation in a variety of S. 
sanguinis strains and incubation conditions 
 
This model depicts proposed levels of gene activity by CSP or IPTG in biofilms in variety 
of strains.  (+) indicates minimal (++) moderate and (+++) high levels of gene expression.  
Each gene is indicated by a colored arrowed, and its corresponding protein is represented 
by a symbol of the same color. The hypothetical CSP exporter is indicated in purple. 
Lastly, the resulting amounts and morphology of biofilm in each model is illustrated 
surrounding the cell.  
  
A. Basal biofilm  
 
B. Increased SSA_0195 production due to IPTG induction of cloned gene or by CSP 
addition 
 
C. comX mutant 
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Figure 23.  
 
 
 
A 
B 
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Figure 23 C. 
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In conclusion, this study has demonstrated the com regulon is not important in 
endocarditis virulence, but is essential for biofilm enhancement and structure. Taken 
together with the fact that S. sanguinis is an important component of a healthy plaque (10), 
this may allow studies which investigate increasing S. sanguinis biofilm levels within the 
oral cavity without increasing endocarditis virulence.  
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